Xenith Bankshares (HMPR) 10-Q 10 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	Apr. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Xenith Bankshares, Inc.
Entity Central Index Key	1,143,155
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		23,160,473

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Assets
Cash and due from banks	$ 16,187	$ 18,825
Interest-bearing deposits in other banks	7,593	4,797
Overnight funds sold and due from Federal Reserve Bank	156,361	103,372
Investment securities available for sale, at fair value	318,741	317,443
Restricted equity securities, at cost	19,296	24,313
Loans	2,356,808	2,464,056
Allowance for loan losses	(18,275)	(21,940)
Net loans	2,338,533	2,442,116
Premises and equipment, net	56,371	56,996
Interest receivable	8,487	8,806
Other real estate owned and repossessed assets, net of valuation allowance	5,185	5,345
Goodwill	26,931	26,931
Core deposit intangible, net	3,656	3,787
Net deferred tax assets, net of valuation allowance	154,899	157,825
Bank-owned life insurance	72,580	72,104
Other assets	13,760	13,969
Assets of discontinued operations	0	10,563
Totals assets	3,198,580	3,267,192
Deposits:
Noninterest-bearing demand	535,889	501,678
Interest-bearing:
Demand and money market	1,148,199	1,113,453
Savings	91,605	86,739
Time deposits less than $250	773,158	785,303
Time deposits $250 or more	70,792	84,797
Total deposits	2,619,643	2,571,970
Federal Home Loan Bank borrowings	50,000	172,000
Other borrowings	38,938	38,813
Interest payable	785	829
Other liabilities	18,143	19,093
Liabilities of discontinued operations	579	849
Total liabilities	2,728,088	2,803,554
Commitments and contingencies
Shareholders' equity:
Preferred stock, 1,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 23,159,377 and 23,123,518 shares issued and outstanding on March 31,2017 and December 31, 2016, respectively	232	231
Capital surplus	712,048	710,916
Accumulated deficit	(239,875)	(245,538)
Accumulated other comprehensive loss, net of tax	(1,913)	(2,428)
Total shareholders' equity before non-controlling interest	470,492	463,181
Non-controlling interest of discontinued operations	0	457
Total shareholders' equity	470,492	463,638
Total liabilities and shareholders' equity	$ 3,198,580	$ 3,267,192

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock authorized (in shares)	1,000,000	1,000,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	1,000,000,000	1,000,000,000
Common stock issued (in shares)	23,159,377	23,123,518
Common stock outstanding (in shares)	23,159,377	23,123,518

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Interest Income
Loans, including fees	$ 27,359	$ 16,584
Investment securities	2,068	1,350
Overnight funds sold and deposits in other banks	236	44
Total interest income	29,663	17,978
Deposits:
Demand and money market	1,584	846
Savings	56	16
Time deposits	2,319	1,864
Interest expense on deposits	3,959	2,726
Federal Home Loan Bank borrowings	173	18
Other borrowings	680	472
Total interest expense	4,812	3,216
Net interest income	24,851	14,762
Provision for loan losses	9	(25)
Net interest income after provision for loan losses	24,842	14,787
Noninterest Income
Service charges on deposit accounts	1,160	1,139
Earnings from bank-owned life insurance	476	349
Gain on sale of loans	19	0
Visa check card income	753	641
Other	724	384
Total noninterest income	3,132	2,513
Noninterest Expense
Salaries and employee benefits	10,487	7,771
Professional and consultant fees	1,199	585
Occupancy	1,981	1,416
FDIC insurance	729	414
Data processing and technology	1,026	1,204
Problem loan and repossessed asset costs	99	101
Impairments on and (gains) and losses from sales of other real estate owned and repossessed assets, net	70	(177)
Equipment	334	284
Board fees	131	246
Advertising and marketing	224	50
Merger-related	250	1,568
Other	3,001	2,071
Total noninterest expense	19,531	15,533
Income from continuing operations before provision for income taxes	8,443	1,767
Provision for income taxes - continuing operations	2,704	734
Net income from continuing operations	5,739	1,033
Net (loss) income from discontinued operations before provision for income taxes	(255)	570
(Benefit) provision for income taxes - discontinued operations	(56)	15
Net (loss) income from discontinued operations attributable to non-controlling interest	(123)	206
Net (loss) income from discontinued operations	(76)	349
Net income attributable to Xenith Bankshares, Inc.	$ 5,663	$ 1,382

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income attributable to Xenith Bankshares, Inc.	$ 5,663	$ 1,382
Other comprehensive income, net of tax:
Change in unrealized gain on securities available for sale	793	1,893
Income tax effect	(278)	(685)
Other comprehensive income, net of tax	515	1,208
Comprehensive income attributable to Xenith Bankshares, Inc.	$ 6,178	$ 2,590

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY - 3 months ended Mar. 31, 2017 - USD ($) $ in Thousands	Total	Common Stock	Capital Surplus	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss), Net of Tax	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2016		23,123,518
Beginning balance at Dec. 31, 2016	$ 463,638	$ 231	$ 710,916	$ (245,538)	$ (2,428)	$ 457
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,540			5,663		(123)
Other comprehensive income, net of tax	515				515
Share-based compensation expense	624		624
Net settlement of restricted stock units (in shares)		2,528
Net settlement of restricted stock units	236	$ 0	236
Restricted stock awards granted (in shares)		13,323
Net issuance on exercise of stock options (in shares)		20,008
Net issuance on exercise of stock options	273	$ 1	272
Reclassification to other liabilities	(334)					(334)
Ending balance (in shares) at Mar. 31, 2017		23,159,377
Ending balance at Mar. 31, 2017	$ 470,492	$ 232	$ 712,048	$ (239,875)	$ (1,913)	$ 0

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities
Net income from continuing operations	$ 5,739	$ 1,033
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	742	734
Deferred income tax expense	2,704	734
Accretion and amortization of fair value adjustments	(890)	272
Amortization of core deposit intangible	131	0
Provision for loan losses	9	(25)
Share-based compensation expense	624	420
Net amortization of premiums and accretion of discounts on investment securities available for sale	868	59
Earnings from bank-owned life insurance	(476)	(349)
Impairments on and gains and losses from sales of other real estate owned and repossessed assets	70	(177)
Impairments on and gains and losses from sales of premises and equipment	(2)	0
Changes in:
Interest receivable	319	(189)
Other assets	209	4,584
Interest payable	(44)	18
Other liabilities	(714)	6,823
Net cash provided by operating activities - continuing operations	9,289	13,937
Net cash provided by (used in) operating activities - discontinued operations	9,704	(2,614)
Cash provided by operating activities	18,993	11,323
Cash flows from investing activities
Proceeds from maturities and calls of investment securities available for sale	8,920	8,892
Purchase of investment securities available for sale	(10,293)	(8,000)
Proceeds from sale of restricted equity securities	7,310	4,122
Purchase of restricted equity securities	(2,293)	(6,299)
Net decrease in loans	104,465	19,575
Proceeds from sale of other real estate owned and repossessed assets, net	214	5,107
Purchases of premises and equipment	(115)	(108)
Net cash provided by investing activities - continuing operations	108,208	23,289
Net cash provided by (used in) investing activities - discontinued operations	0	(1,321)
Cash provided by investing activities	108,208	21,968
Cash flows from financing activities
Net increase (decrease) in deposits	47,673	(20,887)
Net decrease in short-term Federal Home Loan Bank borrowings	(122,000)	(14,000)
Issuance of common stock related to exercised options	273	0
Repurchase of common stock in the settlement of restricted stock units	0	(45)
Distributed non-controlling interest	0	(173)
Net cash used in financing activities	(74,054)	(35,105)
Increase (decrease) in cash and cash equivalents	53,147	(1,814)
Cash and cash equivalents at beginning of period	126,994	63,746
Cash and cash equivalents at end of period	180,141	61,932
Supplemental cash flow information:
Cash paid for interest	4,850	3,070
Cash paid for income taxes	0	0
Supplemental non-cash information:
Change in unrealized gain on investment securities available for sale, net of tax	515	1,208
Transfer from other real estate owned and repossessed assets to loans	0	545
Transfer from other real estate owned and repossessed assets to other assets	0	993
Transfer from loans to other real estate owned and repossessed assets	$ 124	$ 734

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Xenith Bankshares, Inc. ("Xenith Bankshares" or the "Company") is the bank holding company for Xenith Bank (the "Bank"), a Virginia-based institution headquartered in Richmond, Virginia. As of March 31, 2017, the Company, through the Bank, operates 42 full-service branches and two loan production offices. Xenith Bank is a commercial bank specifically targeting the banking needs of middle market and small business, local real estate developers and investors, and retail banking clients. The Bank offers marine finance floorplan and end-user loans through its Shore Premier Finance unit. Xenith Bank's regional area of operations spans from Baltimore, Maryland, to Raleigh and eastern North Carolina, complementing its significant presence in greater Washington, D.C., greater Richmond, Virginia, and greater Hampton Roads, Virginia. Effective July 29, 2016, the Company (previously, Hampton Roads Bankshares, Inc.) completed its merger (the "Merger") with legacy Xenith Bankshares, Inc., a Virginia corporation ("Legacy Xenith"), pursuant to an Agreement and Plan of Reorganization (the "Merger Agreement"), dated as of February 10, 2016, by and between the Company and Legacy Xenith. At the effective time of the Merger, Legacy Xenith merged with and into the Company, with the Company surviving the Merger. Also at the effective time of the Merger, the Company changed its name from "Hampton Roads Bankshares, Inc." to "Xenith Bankshares, Inc." and changed its ticker symbol to "XBKS." Pursuant to the Merger Agreement, holders of Legacy Xenith common stock, par value $1.00 per share, received 4.4 shares of common stock of the Company, par value $0.01 per share (the "common stock"), for each share of Legacy Xenith common stock held immediately prior to the effective time of the Merger, with cash paid in lieu of fractional shares. Each outstanding share of the Company common stock remained outstanding and was unaffected by the Merger. Pursuant to the Merger Agreement and immediately following the completion of the Merger, legacy Xenith Bank, a Virginia banking corporation and wholly owned subsidiary of Legacy Xenith, merged (the "Bank Merger") with and into the Bank, with the Bank surviving the Bank Merger. In connection with the Bank Merger, the Bank changed its name from "The Bank of Hampton Roads" to "Xenith Bank." Unless otherwise stated herein or the context otherwise requires, references herein to "the Company" prior to the effective time of the Merger are to Hampton Roads Bankshares, Inc. and its wholly-owned subsidiaries, and references to "the Bank" are to The Bank of Hampton Roads. Unless otherwise stated herein or the context otherwise requires, references herein to "the Company" after the effective time of the Merger are to Xenith Bankshares, Inc. (f/k/a Hampton Roads Bankshares, Inc.) and its wholly-owned subsidiaries, and references to "the Bank" are to Xenith Bank (f/k/a The Bank of Hampton Roads). Information presented herein as of and for the three-month period ended March 31, 2016 does not include the operations of Legacy Xenith. On September 16, 2016, the Company announced its decision to cease operations of its mortgage banking business. In connection with this decision, the Bank entered into a definitive asset purchase agreement to sell certain assets of Gateway Bank Mortgage, Inc., a wholly-owned subsidiary of the Bank ("GBMI"), and to transition GBMI's operations, which included originating, closing, funding and selling first lien residential mortgage loans, to an unrelated party (the "GBMI Sale"). The completion of the GBMI Sale occurred on October 17, 2016. The operations of GBMI have been reported as discontinued operations for all periods presented herein. On December 7, 2016, the Company announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 (the "Reverse Stock Split"), which had been previously approved by the Company's shareholders. The Reverse Stock Split became effective on December 13, 2016. No fractional shares were issued in the Reverse Stock Split, rather shareholders of fractional shares received a cash payment based on the closing price of the Company's common stock as of the date of the Reverse Stock Split. The par value of each share of common stock remained unchained at $0.01 per share and the number of authorized shares was not affected. References made to outstanding shares or per share amounts in the accompanying consolidated financial statements and disclosures have been retroactively adjusted to reflect the Reverse Stock Split, unless otherwise noted. The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial reporting and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the financial statements reflect all adjustments (consisting of a normal recurring nature) considered necessary for a fair presentation. The results of operations for the three months ended March 31, 2017 are not necessarily indicative of the results to be expected for the full year. The Company has one banking subsidiary, the Bank, which constitutes substantially all of the Company's assets and operations. Certain comparative balances have been reclassified to reflect current presentation. Any reclassification had no effect on total assets, total shareholders' equity or net income. All dollar amounts included in the tables in these notes are in thousands, except per share data, unless otherwise stated. For further information, refer to the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 ("2016 Form 10-K"). Use of Estimates in the Preparation of Financial Statements The preparation of consolidated financial statements in conformity with GAAP requires management to make assumptions, judgments and estimates that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term are the determination of the allowance for loan losses, the valuation of other real estate owned and repossessed assets, the valuation of net deferred tax assets, the determination of fair value for financial instruments, and the determination of fair values of loans and other assets acquired and liabilities assumed in the Merger. Recent Accounting Pronouncements During the second quarter of 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers " ("ASU 2014-09"). ASU 2014-09 represents a comprehensive reform of many of the revenue recognition requirements in GAAP. ASU 2014-09 creates a new topic Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC 606"). ASC 606 will supersede the current revenue recognition requirements in ASC 605, Revenue Recognition , and supersede or amend much of the industry-specific revenue recognition guidance found throughout the ASC. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 creates a five-step process for achieving that core principle: (1) identifying the contract with the customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations; and (5) recognizing revenue when an entity has completed the performance obligations. ASC 606 also requires additional disclosures that allow users of the financial statements to understand the nature, timing and uncertainty of revenue and cash flows resulting from contracts with customers. The effective date of ASC 606 is for the year beginning January 1, 2018. The new revenue standard permits the use of retrospective or cumulative effect transition methods. A majority of the Company's contracts with customers (i.e., financial instruments) do not fall within the scope of ASC 606; therefore, the Company does not expect the adoption of this standard to have a material effect on the Company's consolidated financial statements. In February 2016, the FASB issued ASC Topic 842, Leases ("ASC 842"), which replaces ASC 840, Leases . The core principle of ASC 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in its balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The recognition, measurement and presentation of expenses, and cash flows arising from a lease by a lessee are as follows: For finance leases, a lessee is required to do the following: 1. Recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position; 2. Recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income; and 3. Classify repayments of principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, a lessee is required to do the following: 1. Recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position; 2. Recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis; and 3. Classify all cash payments within operating activities in the statement of cash flows. The effective date for ASC 842 is for annual periods, and interim periods within those annual periods, beginning after December 15, 2018. Early adoption is permitted. The Company is evaluating whether adoption of this standard will have a material effect on the Company's consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting ("ASU 2016-09"), which is intended to improve the accounting for share-based payment transactions as part of the FASB's simplification initiative. ASU 2016-09 changes seven aspects of the accounting for share-based payment award transactions, including: (1) accounting for income taxes; (2) classification of excess tax benefits on the statement of cash flows; (3) forfeitures; (4) minimum statutory tax withholding requirements; (5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes; (6) practical expedient - expected term (nonpublic entities only); and (7) intrinsic value (nonpublic entities only). ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within those years. The implementation of this standard occurred in the current period and did not have a material effect on the Company's consolidated financial statements. In accordance with ASU 2016-09 and beginning in 2017, the Company will recognize excess tax benefits and tax deficiencies as income tax benefit or expense, respectively, in the reporting period in which they occur. Prior to the adoption of this standard, the Company recognized excess tax benefits as capital surplus only when the amounts reduced taxes payable. Additionally, under the updated guidance, the Company will classify excess tax benefits as an operating activity as part of cash payments for taxes on its consolidated statement of cash flows. Under the new guidance, companies are permitted to make an election to account for forfeitures as they occur, rather than estimating forfeitures as of the award's grant date. The Company recognizes forfeitures as they occur, so the new guidance had no effect on the Company's accounting for forfeitures. The Company classifies tax payments made on behalf of employees as cash outflows from financing activities on the statement of cash flows, which results in no change under the new guidance. In June 2016, the FASB issued ASC 326, Measurement of Credit Losses on Financial Instruments ("ASC 326"), which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life. The main objective of ASC 326 is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in ASC 326 replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This standard is effective for annual and interim periods in fiscal years beginning after December 15, 2019. An entity may early adopt the standard for annual and interim periods in fiscal years beginning after December 15, 2018. The Company is evaluating the impact the adoption of this standard will have on the Company's consolidated financial statements. In August 2016, the FASB issued ASC 230, Statement of Cash Flows ("ASC 230"), which is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The guidance addresses: (1) debt prepayment on debt extinguishment costs; (2) settlement of zero-coupon debt instruments; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investments; (7) beneficial interest in securitizations transactions; and (8) separately identifiable cash flows and application of the predominance principle. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017 and interim periods within those years. Early adoption is permitted, including adoption in an interim period. The Company believes the adoption of this standard will not have a material effect on its consolidated statements of cash flows. In October 2016, the FASB issued ASC 740, Income Taxes (Topic 740): Intra-Equity Transfers of Assets Other Than Inventory ("ASC 740"), which requires entities to recognize at the transaction date the income tax consequences of intercompany asset transfers other than inventory. This ASC is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Entities may early adopt the standard, but only at the beginning of an annual period for which no financial statements (interim or annual) have already been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash ("ASU 2016-18"), which requires companies to include cash and cash equivalents that have restrictions on withdrawal or use in total cash and cash equivalents on the statement of cash flows. ASU 2016-18 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted, including adoptions in an interim period. If an entity early adopts the amendments in an interim period, adjustments should be reflected at the beginning of the fiscal year that includes the interim period. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In December 2016, the FASB issued ASU 2016-19, Technical Corrections and Improvements ("ASU 2016-19"), which amends a number of topics in the FASB ASC. The ASU is part of an ongoing FASB project to facilitate ASC updates for non-substantive technical corrections, clarifications and improvements that are not expected to have a significant effect on accounting practice or create a significant administrative cost to most entities. ASU 2016-19 will apply to all reporting entities within the scope of the effected accounting guidance. Most amendments included in ASU 2016-19 were effective upon issuance (December 2016). Certain amendments that require transition guidance are effective for: 1. Public business entities for annual and interim periods in fiscal years beginning after December 2016 (for cloud computing arrangements); and 2. All entities for annual and interim periods in fiscal years beginning after December 15, 2016 (for certain others, including the change to fair value measurement disclosures). Early adoption is permitted for the amendments that require transition guidance. The adoption of this guidance did not have a material effect the Company's consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business ("ASU 2017-01"), which provides a new framework for determining whether transactions should be accounted for as acquisitions or dispositions of assets or businesses. ASU 2017-01 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Entities may early adopt ASU 2017-01 and apply it to transactions that have not been reported in financial statements that have been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment ("ASU 2017-04"), which requires an entity to no longer perform a hypothetical purchase price allocation to measure goodwill impairment. Instead, impairment will be measured using the difference between the carrying amount and the fair value of the reporting unit. ASU 2017-04 is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Entities may early adopt the standard for goodwill impairment tests with measurement dates after January 1, 2017. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), which requires companies to present the service cost component of net benefit cost in the same line items which they report compensation costs. Companies will be required to present all other components of net benefit cost outside of operating income, if this subtotal is presented. ASU 2017-07 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or make available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements.

Business Combination

Business Combination	3 Months Ended
	Mar. 31, 2017
Business Combinations [Abstract]
Business Combination	Business Combination The Company has accounted for the Merger under the acquisition method of accounting, in accordance with ASC Topic 805, Business Combinations , whereby the acquired assets and assumed liabilities are recorded by the Company at their estimated fair values as of the effective date of the Merger, which was July 29, 2016. The Merger combined two banks with complementary capabilities and geographical focus, thus provided the opportunity for the organization to leverage its existing infrastructure, including people, processes and systems, across a larger asset base. In accordance with the framework established by ASC Topic 820, Fair Value Measurements and Disclosure , the Company used a fair value hierarchy to prioritize the information used to form assumptions and estimates in determining fair values. These fair value hierarchies are further discussed in Note 14 - Fair Value Measurements in these consolidated financial statements. The following table presents the summary unaudited balance sheet of Legacy Xenith as of the date of the Merger inclusive of the estimated fair value adjustments and the allocation of consideration paid in the Merger to the acquired assets and assumed liabilities. The allocation resulted in goodwill of $26.9 million , which represents the growth opportunities and franchise value the Bank has in the markets it serves. Fair value of assets acquired: Cash and cash equivalents $ 69,241 Securities 139,025 Loans 827,987 Premises and equipment 6,180 Other real estate owned 738 Core deposit intangible 4,006 Accrued interest receivable 4,464 Deferred tax asset 5,156 Bank owned life insurance 19,917 Other assets 17,879 Total assets $ 1,094,593 Fair value of liabilities assumed: Deposits $ 956,078 Accrued interest payable 285 Supplemental executive retirement plan 2,162 Borrowings 36,533 Other liabilities 8,112 Total liabilities $ 1,003,170 Net identifiable assets acquired $ 91,423 Consideration paid: Company's common shares issued (1) 58,915,439 Purchase price per share (2) $ 1.97 Value of common stock issued $ 116,063 Estimated fair value of stock options 2,290 Cash in lieu of fractional shares 1 Total consideration paid 118,354 Goodwill $ 26,931 _______________________ (1) The issuance of shares of common stock in the Merger preceded the Reverse Stock Split and the number of shares of common stock is presented on a pre-Reverse Stock Split basis. (2) The value of the shares of common stock exchanged for shares of Legacy Xenith common stock was based upon the closing price of common stock at July 28, 2016, the last trading day prior to the date of completion of the Merger. The following table presents the purchased performing and purchased impaired loans receivable at the date of the Merger and the fair value adjustments recorded immediately following the Merger: Purchased Performing Purchased Impaired Total Principal payments receivable $ 830,613 $ 9,851 $ 840,464 Fair value adjustment - credit and interest (9,318 ) (3,159 ) (12,477 ) Fair value of acquired loans $ 821,295 $ 6,692 $ 827,987 The following table presents, on a pro forma basis, the effect of the Merger for the three months ended March 31, 2016, as if the Merger had occurred at the beginning of 2016. Merger-related costs of $1.6 million incurred in the three months ended March 31, 2016, which are included in the Company's consolidated statements of income, are not included in the pro forma information below. Merger-related costs incurred by Legacy Xenith prior to the completion of the Merger are not included in the Company's consolidated statements of income and are also not included in the pro forma information below. Net income includes pro forma adjustments for the accretion of estimated fair value adjustments (discounts) on acquired loans and amortization of core deposit intangibles. An effective income tax rate of 35% was used in determining pro forma net income. Three Months Ended March 31, 2016 Revenue (net interest income plus noninterest income) $ 26,869 Net income from continuing operations $ 4,304 Earnings per common share (basic and diluted) $ 0.19

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations In connection with the GBMI Sale, which was completed on October 17, 2016, GBMI ceased taking new mortgage loan applications, and all applications with prospective borrowers that were in process at the completion of the GBMI Sale were managed by GBMI through funding and sale to investors in the ordinary course of business. The decision to exit the mortgage business was based on a number of factors, including the costs of regulatory compliance and the scale required to be competitive. Proceeds from the GBMI Sale, which included the sale of certain fixed assets, were $87 thousand . As of December 31, 2016, there were no remaining loans to be funded and $9.9 million of loans were held for sale to investors related to GBMI, which are included in assets from discontinued operations in the Company's consolidated balance sheet as of December 31, 2016. As of March 31, 2017, the operations of GBMI had been transitioned to the purchaser and there were no remaining loans held for sale and no assets remaining related to GBMI. Management believes, as of March 31, 2017, there are no significant on-going obligations, which include the Company's share of obligations to third-party investors and certain wind-down expenses, with respect to the mortgage banking business. As of March 31, 2017, the Company had a liability of $579 thousand recorded as liabilities of discontinued operations on its consolidated balance sheets, which is a reserve for any future obligations. The following table presents summarized operating results of the discontinued operations for the period stated: Three Months Ended March 31, 2017 March 31, 2016 Net interest income $ 19 $ 154 Provision for loan losses (5 ) 26 Net interest income after provision for loan losses 24 128 Noninterest income 140 4,439 Noninterest expense: Salaries and employee benefits 237 3,010 Professional and consultant fees 2 49 Occupancy 5 206 Data processing 40 104 Equipment 2 20 Advertising and marketing 6 220 Other 127 388 Total noninterest expense 419 3,997 Net (loss) income before provision for income taxes (255 ) 570 (Benefit) provision for income taxes (56 ) 15 Net (loss) income (199 ) 555 Net (loss) income attributable to non-controlling interest (123 ) 206 Net (loss) income attributable to Xenith Bankshares, Inc. $ (76 ) $ 349

Cash Reserves

Cash Reserves	3 Months Ended
	Mar. 31, 2017
Cash and Cash Equivalents [Abstract]
Cash Reserves	Cash Reserves To comply with regulations of the Board of Governors of the Federal Reserve System (the "Federal Reserve"), the Bank is required to maintain certain average cash reserve balances. The daily average cash reserve requirements for the periods closest to March 31, 2017 and December 31, 2016 were $60.1 million and $63.9 million , respectively. The Bank was in compliance with these requirements at March 31, 2017 and December 31, 2016.

Investment Securities

Investment Securities	3 Months Ended
	Mar. 31, 2017
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment Securities The following table presents amortized cost, gross unrealized gains and losses, and fair values of investment securities available for sale as of the dates stated: March 31, 2017 Gross Gross Unrealized Unrealized Amortized Cost Gains Losses Fair Value Mortgage-backed securities Agencies $ 139,616 $ 736 $ 898 $ 139,454 Collateralized 62,075 61 1,026 61,110 Collateralized mortgage obligations 18,181 259 108 18,332 Asset-backed securities 14,868 — 109 14,759 Municipals Tax-exempt 66,938 — 2,577 64,361 Taxable 18,056 — 387 17,669 Corporate bonds 980 1 — 981 Equity securities 969 1,106 — 2,075 Total securities available for sale $ 321,683 $ 2,163 $ 5,105 $ 318,741 December 31, 2016 Gross Gross Unrealized Unrealized Amortized Cost Gains Losses Fair Value Mortgage-backed securities Agencies $ 135,054 $ 793 $ 957 $ 134,890 Collateralized 63,837 61 1,145 62,753 Collateralized mortgage obligations 19,626 288 104 19,810 Asset-backed securities 14,866 — 108 14,758 Municipals Tax-exempt 67,738 — 2,983 64,755 Taxable 18,105 1 430 17,676 Corporate bonds 983 1 — 984 Equity securities 969 848 — 1,817 Total securities available for sale $ 321,178 $ 1,992 $ 5,727 $ 317,443 As of March 31, 2017 and December 31, 2016, the Company had available-for-sale securities with a fair value of $80.1 million and $83.0 million , respectively, pledged as collateral for public deposits, borrowings and other depositor requirements. Unrealized Losses The following tables present the fair values and gross unrealized losses aggregated by investment category and length of time and the number of individual securities that have been in a continuous unrealized loss position as of the dates stated: March 31, 2017 Less than 12 Months 12 Months or More Total Number of Unrealized Unrealized Unrealized Securities Fair Value Loss Fair Value Loss Fair Value Loss Mortgage-backed securities Agencies 36 $ 87,594 $ 893 $ 640 $ 5 $ 88,234 $ 898 Collateralized 20 47,099 1,026 — — 47,099 1,026 Collateralized mortgage obligations 7 7,218 108 — — 7,218 108 Asset-backed securities 6 5,443 64 9,315 45 14,758 109 Municipals Tax-exempt 43 64,361 2,577 — — 64,361 2,577 Taxable 10 17,669 387 — — 17,669 387 Total securities available for sale 122 $ 229,384 $ 5,055 $ 9,955 $ 50 $ 239,339 $ 5,105 December 31, 2016 Less than 12 Months 12 Months or More Total Number of Unrealized Unrealized Unrealized Securities Fair Value Loss Fair Value Loss Fair Value Loss Mortgage-backed securities Agencies 33 $ 88,315 $ 945 $ 695 $ 12 $ 89,010 $ 957 Collateralized 19 42,272 1,145 — — 42,272 1,145 Collateralized mortgage obligations 6 7,216 104 — — 7,216 104 Asset-backed securities 6 5,443 64 9,315 44 14,758 108 Municipals Tax-exempt 44 64,755 2,983 — — 64,755 2,983 Taxable 9 17,149 430 — — 17,149 430 Total securities available for sale 117 $ 225,150 $ 5,671 $ 10,010 $ 56 $ 235,160 $ 5,727 Management evaluates securities for other-than-temporary impairment ("OTTI") at least quarterly and more frequently when economic or market conditions warrant such an evaluation. In determining OTTI, management considers many factors, including (1) the length of time and the extent to which the fair value has been less than cost; (2) the financial condition and near-term prospects of the issuer; (3) whether the market decline was affected by macroeconomic conditions; and (4) whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before its anticipated recovery. The assessment of whether an OTTI decline exists involves a high degree of subjectivity and judgment and is based on the information available to management at a point in time. In instances where an unrealized loss did occur, there was no indication of an adverse change in credit on any of the underlying securities in the tables above, and management believes no individual unrealized loss represented an OTTI as of those dates. The Company does not intend to sell, and it is not more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis, which may be at maturity. Maturities of Investment Securities The following table presents the amortized cost and fair value by contractual maturity of investment securities available for sale as of the dates stated. Expected maturities may differ from contractual maturities, as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Securities that are not due at a single maturity date and equity securities that do not have contractual maturities are shown separately. March 31, 2017 December 31, 2016 Amortized Amortized Cost Fair Value Cost Fair Value Due in one year or less $ 259 $ 258 $ 502 $ 502 Due after one year but less than five years 12,050 11,850 11,300 11,072 Due after five years but less than ten years 68,556 65,934 69,900 66,880 Due after ten years 4,128 3,988 4,141 3,977 Mortgage-backed securities Agencies 139,616 139,454 135,054 134,890 Collateralized 62,075 61,110 63,837 62,753 Collateralized mortgage obligations 18,181 18,332 19,626 19,810 Corporate Bonds 981 981 983 984 Asset-backed securities 14,868 14,759 14,866 14,758 Equity securities 969 2,075 969 1,817 Total securities available for sale $ 321,683 $ 318,741 $ 321,178 $ 317,443 Restricted Equity Securities The Company's holds stock in the Federal Home Loan Bank ("FHLB") in the amount of $5.1 million and $10.1 million at March 31, 2017 and December 31, 2016 , respectively. FHLB stock is generally viewed as a long-term investment and as a restricted investment security, as it is required to be held in order to access FHLB advances (i.e., borrowings). The Company earns dividends from its investment in FHLB stock, and for the three months ended March 31, 2017 , recorded an annualized dividend rate of 4.77% . The investment in FHLB stock is carried at cost as there is no active market or exchange for the stock other than the FHLB or member institutions. The Company holds stock in the Federal Reserve Bank ("FRB") in the amount of $14.0 million at March 31, 2017 and at December 31, 2016 . FRB stock is generally viewed as a long-term investment and as a restricted investment security, as it is required to be held to effect membership in the Federal Reserve. It is carried at cost as there is not an active market or exchange for the stock other than the FRB or member institutions. The remaining restricted stock held by the Company, in the amount of $178 thousand at March 31, 2017 and December 31, 2016, is stock in other banks with which the Bank conducts or has the ability to conduct correspondent activity. These investments are also carried at cost as there is no readily available market for these securities.

Loans and Allowance for Loan Lo

Loans and Allowance for Loan Losses	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Loans and Allowance for Loan Losses	Loans and Allowance for Loan Losses Loans are carried at their unpaid principal amount outstanding net of unamortized fees and origination costs, partial charge-offs, if any, and in the case of acquired loans, unaccreted fair value or purchase accounting adjustments. All lending decisions are based upon a thorough evaluation of the financial strength and credit history of the borrower and the quality and value of the collateral securing the loan. The Company makes owner-occupied real estate ("OORE") loans, which are secured in part by the real estate that is generally the offices or production facilities of the borrower. In some cases, the real estate is not held by the commercial enterprise, rather it is owned by the principals of the business or an entity controlled by the principals. The Company classifies OORE loans as commercial and industrial, as the primary source of repayment of the loan is generally dependent on the financial performance of the commercial enterprise occupying the property, with the real estate being a secondary source of repayment. All periods presented herein reflect this classification. The Company holds guaranteed student loans ("GSLs"), which were purchased by Legacy Xenith in 2013 and acquired by the Company in the Merger. These loans were originated under the Federal Family Education Loan Program ("FFELP"), authorized by the Higher Education Act of 1965, as amended. Pursuant to the FFELP, the student loans are substantially guaranteed by a guaranty agency and reinsured by the U.S. Department of Education. The purchased loans were also part of the Federal Rehabilitated Loan Program ("FRLP"), under which borrowers on defaulted loans have the one-time opportunity to bring their loans current. These loans, which are then owned by an agency guarantor, are brought current and sold to approved lenders. The Company has an agreement with a third-party servicer of student loans to provide all day-to-day operational requirements for the servicing of the loans. The GSLs carry a nearly 98% guarantee of principal and accrued interest. In allocating the consideration paid in the Merger, the Company recorded a fair value adjustment for GSLs that reduced the carrying amount in the GSLs to approximate the guaranteed portion of the loans. In the three-month period ended March 31, 2017, the Company sold a portion of the GSLs. The proceeds from the sale were $9.9 million , and the gain on the sale was $19 thousand , which is recorded in noninterest income on the Company's consolidated statements of income. The following table presents the Company's composition of loans as of the dates stated: March 31, 2017 December 31, 2016 Commercial & Industrial $ 787,443 $ 895,952 Construction 255,309 257,712 Commercial real estate 591,739 585,727 Residential real estate 391,971 405,291 Consumer 296,781 274,008 Guaranteed student loans 32,533 44,043 Deferred loan fees and related costs 1,032 1,323 Total loans $ 2,356,808 $ 2,464,056 As of March 31, 2017 and December 31, 2016, the Company had $577.8 million and $625.0 million , respectively, of loans pledged to the FRB and the FHLB as collateral for borrowings. Acquired Loans Acquired loans are initially recorded at estimated fair value as of the date of acquisition; therefore, any related allowance for loan losses is not carried over or established at acquisition. The difference between contractually required amounts receivable and the acquisition date fair value of loans that are not deemed credit-impaired at acquisition is accreted (recognized) into income over the life of the loan either on a straight-line basis or based on the underlying principal payments on the loan. Any deterioration in credit quality subsequent to acquisition for these loans is reflected in the allowance for loan losses at such time the remaining purchase accounting adjustment (discount) for the acquired loans is inadequate to cover the allowance needs of these loans. Loans acquired with evidence of credit deterioration since origination and for which it is probable at the date of acquisition that contractually required principal and interest payments will not be collected are accounted for under ASC 310-30, Loans and Debt Securities Acquired with Deteriorated Credit Quality ("ASC 310-30"). A portion of the loans acquired in the Merger were deemed to be purchased credit-impaired loans qualifying for accounting under ASC 310-30. In applying ASC 310-30 to acquired loans, the Company must estimate the amount and timing of cash flows expected to be collected. The estimation of the amount and timing of expected cash flows to be collected requires significant judgment, including default rates, the amount and timing of prepayments, and the value and timing of the liquidation of underlying collateral, in addition to other factors. ASC 310-30 requires periodic re-evaluation of expected cash flows for purchased credit-impaired loans subsequent to acquisition date. Decreases in expected cash flows attributable to credit will generally result in an impairment charge to earnings such that the accretable yield remains unchanged. Increases in expected cash flows will result in an increase in the accretable yield recognized in income over the remaining period of expected cash flows from the loan. Any impairment charge recorded as a result of a re-evaluation is recorded as an increase in the allowance for loan and lease losses. In the period since the Merger through March 31, 2017, impairment of $9 thousand has been recorded with respect to loans accounted for under ASC 310-30. Acquired loans for which the amount or timing of cash flows cannot be predicted are accounted for under the cost recovery method, whereby principal and interest payments received reduce the carrying value of the loan until such amount has been received. Amounts received in excess of the carrying value are reported in interest income. Allowance for Loan Losses The following table presents the allowance for loan loss activity by loan type for the periods stated: Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 21,940 $ 23,157 Charge-offs: Commercial & Industrial 2,787 258 Construction 55 312 Commercial real estate 720 540 Residential real estate 240 1,603 Consumer 664 19 Guaranteed student loans — — Overdrafts 26 34 Total charge-offs 4,492 2,766 Recoveries: Commercial & Industrial 127 89 Construction 249 268 Commercial real estate 193 222 Residential real estate 221 220 Consumer 28 10 Guaranteed student loans — — Overdrafts — — Total recoveries 818 809 Net charge-offs 3,674 1,957 Provision (benefit) for loan losses 9 (25 ) Balance at end of period $ 18,275 $ 21,175 The Company has no allowance for loan losses on its guaranteed student loan portfolio. In allocating the consideration paid in the Merger, the Company recorded a fair value adjustment for GSLs, which reduced the carrying amount in the portfolio to an amount that approximates the portion of the loans subject to federal guarantee. The following tables present the allowance for loan lease losses, with the amount independently and collectively evaluated for impairment, and loan balances by loan type as of the dates stated: March 31, 2017 Individually Evaluated Collectively Evaluated Total Amount for Impairment for Impairment Allowance for loan losses applicable to: Purchased credit-impaired loans Commercial & Industrial $ — $ — $ — Construction — — — Commercial real estate — — — Residential real estate 9 9 — Consumer — — — Total purchased credit-impaired loans 9 9 — Originated and other purchased loans Commercial & Industrial 4,250 2,324 1,926 Construction 1,130 73 1,057 Commercial real estate 1,747 — 1,747 Residential real estate 4,456 1,445 3,011 Consumer 1,463 40 1,423 Guaranteed student loans — — — Unallocated qualitative 5,220 — 5,220 Total originated and other purchased loans 18,266 3,882 14,384 Total allowance for loan losses $ 18,275 $ 3,891 $ 14,384 Loan balances applicable to: Purchased credit-impaired loans Commercial & Industrial $ 865 $ 865 $ — Construction 978 978 — Commercial real estate 1,050 1,050 — Residential real estate 2,101 2,101 — Consumer 54 54 — Total purchased credit-impaired loans 5,048 5,048 — Originated and other purchased loans Commercial & Industrial 786,578 20,856 765,722 Construction 254,331 7,162 247,169 Commercial real estate 590,689 7,417 583,272 Residential real estate 389,870 12,276 377,594 Consumer 296,727 882 295,845 Guaranteed student loans 32,533 — 32,533 Deferred loan fees and related costs 1,032 — 1,032 Total originated and other purchased loans 2,351,760 48,593 2,303,167 Total loans $ 2,356,808 $ 53,641 $ 2,303,167 December 31, 2016 Individually Evaluated Collectively Evaluated Total Amount for Impairment for Impairment Allowance for loan losses applicable to: Purchased credit-impaired loans Commercial & Industrial $ — $ — $ — Construction — — — Commercial real estate — — — Residential real estate — — — Consumer — — — Total purchased credit-impaired loans — — — Originated and other purchased loans Commercial & Industrial 5,816 3,327 2,489 Construction 1,551 161 1,390 Commercial real estate 2,410 734 1,676 Residential real estate 5,205 1,275 3,930 Consumer 1,967 606 1,361 Guaranteed student loans — — — Unallocated qualitative 4,991 — 4,991 Total originated and other purchased loans 21,940 6,103 15,837 Total allowance for loan losses $ 21,940 $ 6,103 $ 15,837 Loan balances applicable to: Purchased credit-impaired loans Commercial & Industrial $ 897 $ 897 $ — Construction 992 992 — Commercial real estate 1,090 1,090 — Residential real estate 2,122 2,122 — Consumer 55 55 — Total purchased credit-impaired loans 5,156 5,156 — Originated and other purchased loans Commercial & Industrial 895,055 24,052 871,003 Construction 256,720 7,982 248,738 Commercial real estate 584,637 9,184 575,453 Residential real estate 403,169 12,637 390,532 Consumer 273,953 1,551 272,402 Guaranteed student loans 44,043 — 44,043 Deferred loan fees and related costs 1,323 — 1,323 Total originated and other purchased loans 2,458,900 55,406 2,403,494 Total loans $ 2,464,056 $ 60,562 $ 2,403,494 The following tables present the loans that were individually evaluated for impairment as of the dates and for the periods stated. The tables present those loans with and without an allowance and various additional data. March 31, 2017 Recorded Investment Unpaid Principal Balance Related Allowance With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 865 $ 1,254 $ — Construction 978 1,433 — Commercial real estate 1,050 1,471 — Residential real estate 2,047 2,823 — Consumer 54 90 — Originated and other purchased loans Commercial & Industrial 13,362 14,844 — Construction 6,962 16,370 — Commercial real estate 7,417 10,176 — Residential real estate 6,182 6,874 — Consumer 804 1,342 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — Construction — — — Commercial real estate — — — Residential real estate 54 73 9 Consumer — — — Originated and other purchased loans Commercial & Industrial 7,494 7,494 2,324 Construction 200 200 73 Commercial real estate — — — Residential real estate 6,094 6,094 1,445 Consumer 78 78 40 Total loans individually evaluated for impairment $ 53,641 $ 70,616 $ 3,891 December 31, 2016 Recorded Investment Unpaid Principal Balance Related Allowance With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 897 $ 1,298 $ — Construction 992 1,448 — Commercial real estate 1,090 1,520 — Residential real estate 2,122 2,989 — Consumer 55 92 — Originated and other purchased loans Commercial & Industrial 12,809 14,185 — Construction 7,078 16,327 — Commercial real estate 7,131 9,214 — Residential real estate 7,038 7,816 — Consumer 8 28 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — Construction — — — Commercial real estate — — — Residential real estate — — — Consumer — — — Originated and other purchased loans Commercial & Industrial 11,243 16,297 3,327 Construction 904 1,054 161 Commercial real estate 2,053 2,053 734 Residential real estate 5,599 5,631 1,275 Consumer 1,543 1,546 606 Total loans individually evaluated for impairment $ 60,562 $ 81,498 $ 6,103 Three Months Ended March 31, 2017 2016 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 877 $ — $ — $ — Construction 983 — — — Commercial real estate 1,060 — — — Residential real estate 2,054 10 — — Consumer 54 1 — — Originated and other purchased loans Commercial & Industrial 13,733 81 11,995 88 Construction 7,385 71 840 1 Commercial real estate 7,659 65 4,852 17 Residential real estate 6,862 3 5,419 1 Consumer 815 — 15 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — — Construction — — — — Commercial real estate — — — — Residential real estate 55 — — — Consumer — — — — Originated and other purchased loans Commercial & Industrial 7,498 48 11,136 49 Construction 214 — 20,075 49 Commercial real estate — — 4,887 49 Residential real estate 6,170 43 6,480 43 Consumer 84 — 88 — Total loans individually evaluated for impairment $ 55,503 $ 322 $ 65,787 $ 297 The following table presents accretion of acquired loan discounts for the periods stated. The amount of accretion recognized in the periods is dependent on discounts recorded to reflect acquired loans at their estimated fair values as of the date of the Merger. The amount of accretion recognized within a period is based on many factors, including, among other factors, loan prepayments and curtailments; therefore, amounts recognized are subject to volatility. Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 9,030 $ — Additions — — Accretion (1) (1,015 ) — Disposals (2) (300 ) Balance at end of period $ 7,715 $ — _______________________ (1) Accretion amounts are reported in interest income. (2) Disposals represent the reduction of purchase accounting adjustments (loan discounts) due to the resolution of acquired loans at amounts less than the contractually-owed receivable. Of the $12.5 million fair value adjustment recorded as part of the Merger, $3.2 million was related to $9.9 million of purchased credit-impaired loans. The remaining carrying value and fair value adjustment on the purchased credit-impaired loans as of March 31, 2017 were $5.0 million and $2.1 million , respectively. Management believes the Company's allowance for loan losses as of March 31, 2017 is adequate to absorb losses inherent in the portfolio. Although various data and information sources are used to establish the allowance for loan losses, future adjustments to the allowance for loan losses may be necessary, if conditions, circumstances or events are substantially different from the assumptions used in making the assessments. Such adjustments to original estimates, as necessary, are made in the period in which these factors and other relevant considerations indicate that loss levels may vary from previous estimates. In addition, the allowance is subject to regulatory examinations and determination as to adequacy, which may take into account such factors as the methodology used to calculate the allowance and the size of the allowance in comparison to peer banks identified by regulatory agencies. Such agencies may require the Company to recognize additions to the allowance for loan losses based on their judgments about information available at the time of the examinations. Impaired Loans Total impaired loans were $53.6 million and $60.6 million at March 31, 2017 and December 31, 2016 , respectively. Collateral dependent impaired loans were $43.5 million and $50.2 million at March 31, 2017 and December 31, 2016 , respectively, and are measured at the estimated fair value of the underlying collateral less costs to sell. Impaired loans for which no allowance is provided totaled $39.7 million and $39.2 million at March 31, 2017 and December 31, 2016 , respectively. Loans written down to their estimated fair value of collateral less costs to sell account for $9.7 million and $8.1 million of the impaired loans for which no allowance has been provided as of March 31, 2017 and December 31, 2016 , respectively. Nonperforming Assets Nonperforming assets consist of nonaccrual loans and other real estate owned and repossessed assets. As of March 31, 2017 , the Company had no loans other than GSLs that were past due greater than 90 days and accruing interest. The carrying value and accrued interest receivable of GSLs are substantially fully guaranteed by the federal government. Pursuant to the guarantee, the Company may make a claim for payment on the loan after a period of 270 days during which no payment has been made on the loan. Payments of principal and interest are guaranteed up to the date of payment under the guarantee. The following table presents nonperforming assets as of the dates stated: March 31, 2017 December 31, 2016 Purchased credit-impaired loans: Commercial & Industrial $ 865 $ 897 Construction 978 992 Commercial real estate 1,050 1,090 Residential real estate 1,656 1,549 Consumer 37 39 Total purchased credit-impaired loans 4,586 4,567 Originated and other purchased loans: Commercial & Industrial 8,682 11,805 Construction 2,109 2,830 Commercial real estate 2,326 3,686 Residential real estate 7,592 7,931 Consumer 883 1,551 Total originated and other purchased loans 21,592 27,803 Total nonaccrual loans 26,178 32,370 Other real estate owned 5,185 5,345 Total nonperforming assets $ 31,363 $ 37,715 The following table presents a reconciliation of nonaccrual loans to impaired loans as of the dates stated: March 31, 2017 December 31, 2016 Nonaccrual loans $ 26,178 $ 32,370 TDRs on accrual 27,001 27,603 Impaired loans on accrual 462 589 Total impaired loans $ 53,641 $ 60,562 The following table presents a rollforward of nonaccrual loans for the period stated: Commercial & Industrial Construction Commercial real estate Residential real estate Consumer Total Balance at December 31, 2016 $ 12,702 $ 3,822 $ 4,776 $ 9,480 $ 1,590 $ 32,370 Transfers in 3,957 — — 2,103 126 6,186 Transfers to other real estate owned — (19 ) — (105 ) — (124 ) Charge-offs (2,787 ) (55 ) (720 ) (240 ) (690 ) (4,492 ) Payments (3,577 ) (661 ) (183 ) (594 ) (106 ) (5,121 ) Return to accrual (748 ) — (497 ) (1,396 ) — (2,641 ) Loan type reclassification — — — — — — Balance at March 31, 2017 $ 9,547 $ 3,087 $ 3,376 $ 9,248 $ 920 $ 26,178 Age Analysis of Past Due Loans The following presents an age analysis of loans as of the dates stated: March 31, 2017 30-89 days 90+ days Total Total Current Past Due Past Due Past Due Loans Purchased credit-impaired loans: Commercial & Industrial $ 142 $ — $ 723 $ 723 $ 865 Construction 764 34 180 214 978 Commercial real estate 1,050 — — — 1,050 Residential real estate 1,334 54 713 767 2,101 Consumer 17 — 37 37 54 Total purchased credit-impaired loans 3,307 88 1,653 1,741 5,048 Originated and other purchased loans: Commercial & Industrial 780,470 1,598 4,510 6,108 786,578 Construction 251,988 376 1,967 2,343 254,331 Commercial real estate 586,946 1,417 2,326 3,743 590,689 Residential real estate 380,621 5,733 3,516 9,249 389,870 Consumer 295,853 4 870 874 296,727 Guaranteed student loans 23,495 3,957 5,081 9,038 32,533 Deferred loan fees and related costs 1,032 — — — 1,032 Total originated and other purchased loans 2,320,405 13,085 18,270 31,355 2,351,760 Total loans $ 2,323,712 $ 13,173 $ 19,923 $ 33,096 $ 2,356,808 December 31, 2016 30-89 days 90+ days Total Total Current Past Due Past Due Past Due Loans Purchased credit-impaired loans: Commercial & Industrial $ 145 $ 11 $ 741 $ 752 $ 897 Construction 774 181 37 218 992 Commercial real estate 1,090 — — — 1,090 Residential real estate 1,261 297 564 861 2,122 Consumer 16 — 39 39 55 Total purchased credit-impaired loans 3,286 489 1,381 1,870 5,156 Originated and other purchased loans: Commercial & Industrial 883,531 1,714 9,810 11,524 895,055 Construction 254,058 53 2,609 2,662 256,720 Commercial real estate 580,355 2,911 1,371 4,282 584,637 Residential real estate 395,579 5,124 2,466 7,590 403,169 Consumer 272,147 1,630 176 1,806 273,953 Guaranteed student loans 30,909 5,562 7,572 13,134 44,043 Deferred loan fees and related costs 1,323 — — — 1,323 Total originated and other purchased loans 2,417,902 16,994 24,004 40,998 2,458,900 Total loans $ 2,421,188 $ 17,483 $ 25,385 $ 42,868 $ 2,464,056 Credit Quality The following tables present information about the credit quality of the loan portfolio using the Company's internal rating system as an indicator as of the dates stated: March 31, 2017 Special Pass Substandard Total Purchased credit-impaired loans: Commercial & Industrial $ — $ — $ 865 $ 865 Construction — — 978 978 Commercial real estate — — 1,050 1,050 Residential real estate — — 2,101 2,101 Consumer — — 54 54 Total purchased credit-impaired loans — — 5,048 5,048 Originated and other purchased loans: Commercial & Industrial 764,411 12,874 9,293 786,578 Construction 245,087 6,766 2,478 254,331 Commercial real estate 579,273 4,022 7,394 590,689 Residential real estate 353,192 22,297 14,381 389,870 Consumer 293,695 2,135 897 296,727 Guaranteed student loans 32,533 — — 32,533 Deferred loan fees and related costs 1,032 — — 1,032 Total originated and other purchased loans 2,269,223 48,094 34,443 2,351,760 Total loans $ 2,269,223 $ 48,094 $ 39,491 $ 2,356,808 December 31, 2016 Special Pass Substandard Total Purchased credit-impaired loans: Commercial & Industrial $ — $ — $ 897 $ 897 Construction — — 992 992 Commercial real estate — — 1,090 1,090 Residential real estate — — 2,122 2,122 Consumer — — 55 55 Total purchased credit-impaired loans — — 5,156 5,156 Originated and other purchased loans: Commercial & Industrial 873,180 9,391 12,484 895,055 Construction 247,335 6,460 2,925 256,720 Commercial real estate 571,781 3,689 9,167 584,637 Residential real estate 366,940 21,646 14,583 403,169 Consumer 270,919 1,467 1,567 273,953 Guaranteed student loans 44,043 — — 44,043 Deferred loan fees and related costs 1,323 — — 1,323 Total originated and other purchased loans 2,375,521 42,653 40,726 2,458,900 Total loans $ 2,375,521 $ 42,653 $ 45,882 $ 2,464,056 Troubled Debt Restructuring ("TDRs") Loans meeting the criteria to be classified as TDRs are included in impaired loans. The following table presents the number of and recorded investment in loans classified as TDRs by management as of the dates stated: March 31, 2017 December 31, 2016 Recorded Recorded Number of Contracts Number of Contracts Commercial & Industrial 13 $ 12,979 13 $ 13,067 Construction 4 5,120 5 5,225 Commercial real estate 6 5,091 7 5,498 Residential real estate 12 4,969 14 5,082 Consumer — — — — Total 35 $ 28,159 39 $ 28,872 Of TDRs, amounts totaling $27.0 million were accruing and $1.2 million were nonaccruing at March 31, 2017 , and $27.6 million were accruing and $1.3 million were nonaccruing at December 31, 2016 . Loans classified as TDRs that are on nonaccrual status at the time of the restructuring generally remain on nonaccrual status for approximately six months before management considers whether such loans may return to accrual status. Loans classified as TDRs in nonaccrual status may be returned to accrual status after a period of performance under which the borrower demonstrates the ability and willingness to repay the loan in accordance with the modified terms. For the three months ended March 31, 2017 , none of the nonaccrual TDRs were returned to accrual status. The following table presents a rollforward of accruing and nonaccruing TDRs for the period stated: Accruing Nonaccruing Total Balance at December 31, 2016 $ 27,603 $ 1,269 $ 28,872 Charge-offs — (7 ) (7 ) Payments (602 ) (104 ) (706 ) New TDR designation — — — Release TDR designation — — — Transfer — — — Balance at March 31, 2017 $ 27,001 $ 1,158 $ 28,159 The following table presents performing and nonperforming loans identified as TDRs, by loan type, as of the dates stated: March 31, 2017 December 31, 2016 Performing TDRs: Commercial & Industrial $ 12,174 $ 12,247 Construction 5,052 5,152 Commercial real estate 5,091 5,498 Residential real estate 4,684 4,706 Consumer — — Total performing TDRs 27,001 27,603 Nonperforming TDRs: Commercial & Industrial 805 820 Construction 68 73 Commercial real estate — — Residential real estate 285 376 Consumer — — Total nonperforming TDRs 1,158 1,269 Total TDRs $ 28,159 $ 28,872 The allowance for loan losses allocated to TDRs was $648 thousand and $705 thousand at March 31, 2017 and December 31, 2016 , respectively. TDR balances charged off were $7 thousand in the three months ended March 31, 2017. There were no loans designated as TDRs by management during the three months ended March 31, 2017 and 2016 . For the three months ended March 31, 2017 and 2016 , the Company had no loans for which there was a payment default and subsequent movement to nonaccrual status that were modified as TDRs within the previous 12 months. The Company had no commitments to lend additional funds to debtors owing receivables whose terms have been modified in TDRs at March 31, 2017 and December 31, 2016 .

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill of $26.9 million and core deposit intangible of $4.0 million were recorded in the allocation of the purchase consideration in the Merger. The core deposit intangible is being amortized over approximately eight years on a straight-line basis. The following table presents goodwill and other intangible assets as of the dates stated. March 31, 2017 December 31, 2016 Amortizable core deposit intangible: Gross amount $ 4,006 $ 4,006 Accumulated amortization (350 ) (219 ) Net core deposit intangible $ 3,656 $ 3,787 Goodwill $ 26,931 $ 26,931

Other Real Estate Owned and Rep

Other Real Estate Owned and Repossessed Assets	3 Months Ended
	Mar. 31, 2017
Other Real Estate Owned and Repossessed Assets [Abstract]
Other Real Estate Owned and Repossessed Assets	Other Real Estate Owned and Repossessed Assets The following table presents a rollforward of other real estate owned and repossessed assets for the period stated: Amount Balance at December 31, 2016 $ 5,345 Transfers in (via foreclosure) 124 Sales (214 ) Gain on sales 6 Impairments (76 ) Balance at March 31, 2017 $ 5,185 As of March 31, 2017 , there were $129 thousand of residential real estate properties included in the balance of other real estate owned and repossessed assets, and the Company held $407 thousand of residential mortgage loans secured by residential real estate properties for which formal foreclosure proceedings were in process. Other real estate owned and repossessed assets are presented net of a valuation allowance. The following table presents an analysis of the valuation allowance on these assets for the periods stated: March 31, 2017 March 31, 2016 Balance at beginning of year $ 3,031 $ 9,875 Impairments 76 72 Charge-offs — (2,991 ) Balance at end of period $ 3,107 $ 6,956 The following table presents amounts applicable to other real estate owned and repossessed assets included in the consolidated statements of income for the periods stated: Three Months Ended March 31, 2017 2016 (Gain) on sales $ (6 ) $ (249 ) Impairments 76 72 Operating expenses 51 52 Total noninterest expense $ 121 $ (125 )

Derivative Instruments

Derivative Instruments	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Derivatives are financial instruments whose value is based on one or more underlying assets. The Company, through GBMI, originated residential mortgage loans for sale into the secondary market on a best efforts basis. In connection with the underwriting process, the Company entered into commitments to lock-in the interest rate of the loan with the borrower prior to funding ("interest rate-lock commitments"). Generally, such interest rate-lock commitments were for periods less than 60 days. These interest rate-lock commitments are considered derivatives. The Company managed its exposure to changes in fair value associated with these interest rate-lock commitments by entering into simultaneous agreements to sell the residential loans to third-party investors shortly after their origination and funding. At March 31, 2017 and December 31, 2016 , the Company had loans held for sale of $0 and $9.9 million , respectively. Loans held for sale at December 31, 2016 were reported in assets from discontinued operations on the Company's consolidated balance sheet. Under the contractual relationship in the best efforts method, the Company was obligated to sell the loans only if the loans close. As a result of the terms of these contractual relationships, the Company was not exposed to changes in fair value nor would it realize gains or losses related to its interest rate-lock commitments due to subsequent changes in interest rates. At March 31, 2017 and December 31, 2016 , the Company had interest rate-lock commitments to originate residential mortgage loans (unfunded par amount of loans) on a best efforts basis in the amounts of $0 and $1.4 million , respectively. The Company's interest rate-lock commitments were reported as discontinued operations at December 31, 2016. The Company has derivative financial instruments not designated as hedges and result from a service the Company provides to meet the needs of certain commercial customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Derivative contracts are executed between the Company and certain commercial loan customers with offsetting positions to dealers under a back-to-back swap arrangement enabling the commercial loan customers to effectively exchange variable-rate interest payments under their existing obligations to the Company for fixed-rate interest payments. These derivatives do not meet hedge accounting requirements; therefore, changes in the fair value of both the customer derivative and the offsetting derivative are recognized in net income. For the three months ended March 31, 2017 and 2016 , the Company recorded $133 thousand and $110 thousand , respectively, of income related to its back-to-back interest rate swap program that was included in other noninterest income on the consolidated statements of income. The Company has minimum collateral requirements with its financial institution counterparties for these back-to-back interest rate swaps that contain provisions, whereby if the Company fails to maintain its status as a well or an adequately capitalized institution, the Company could be required to terminate or fully collateralize the derivative contract. Additionally, if the Company defaults on any of its indebtedness, including default where repayment has not been accelerated by the lender, the Company could also be in default on its derivative obligations. As of March 31, 2017, the Bank had cash and securities in the amount of $6.3 million pledged as collateral under the agreements. If the Company is not in compliance with the terms of the derivative agreements, it could be required to settle its obligations under the agreements at termination value. Certain financial instruments, including derivatives, may be eligible for offset in the consolidated balance sheet and/or subject to master netting arrangements. The Company's derivative transactions with financial institution counterparties are generally executed under International Swaps and Derivative Association (ISDA) master agreements which include right of setoff provisions. In such cases there is generally a legally enforceable right to offset recognized amounts and there may be an intention to settle such amounts on a net basis. However, the Company has not offset financial instruments for financial reporting purposes. The following tables present information about derivatives that are eligible for offset in the consolidated balance sheets as of the dates stated: Gross Net Amounts Gross Amounts Amounts of Assets Not Offset in the Gross Offset in Presented Consolidated Balance Sheets Amounts the in the of Consolidated Consolidated Cash and Security Recognized Balance Balance Financial Collateral Net Assets Sheets Sheets Instruments Received Amount Derivative assets: March 31, 2017 Interest rate swap agreements $ 1,213 $ — $ 1,213 $ 127 $ — $ 1,086 December 31, 2016 Interest rate swap agreements 1,223 — 1,223 53 — 1,170 Gross Net Amounts Gross Amounts Amounts of Liabilities Not Offset in the Gross Offset in Presented Consolidated Balance Sheets Amounts the in the of Consolidated Consolidated Cash and Security Recognized Balance Balance Financial Collateral Net Liabilities Sheets Sheets Instruments Requirement Amount Derivative liabilities: March 31, 2017 Interest rate swap agreements $ 1,138 $ — $ 1,138 $ 127 $ 455 $ 556 December 31, 2016 Interest rate swap agreements 1,226 — 1,226 53 341 832

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The provision for income taxes is based upon the results of operations, adjusted for the effect of certain tax-exempt income and non-deductible expenses. Certain items of income and expense are reported in different periods for financial reporting and tax return purposes resulting in temporary differences. The tax effects of these temporary differences are recognized currently in the deferred income tax provision or benefit on the Company's consolidated statement of operations. As of March 31, 2017, the Company had a net deferred tax asset of $154.9 million recorded on its consolidated balance sheets, which is net of a valuation allowance of $780 thousand . The following table presents the federal statutory tax rate reconciled to the Company's effective tax rate from continuing operations for the period stated: Three Months Ended March 31, 2017 Tax Rate Effective tax rate from continuing operations: Income tax at statutory rate $ 2,955 35.00 % Tax-exempt income (294 ) (3.48 )% Nondeductible expenses 6 0.07 % Other 37 0.43 % Income tax provision from continuing operations $ 2,704 32.02 % Deferred tax assets or liabilities are computed based on the difference between the financial statement and income tax bases of assets and liabilities. These differences will result in deductible or taxable amounts in a future year(s) when the reported amounts of assets or liabilities are recovered or settled. Deferred assets and liabilities are stated at tax rates expected to be in effect in the year(s) the differences reverse. A valuation allowance is recorded against that portion of the deferred tax assets when it is not more likely than not that all or a portion of the asset will be realized. A valuation allowance related to all components of net deferred tax assets was established in 2009 and was adjusted, as necessary, each reporting period. The valuation allowance was established based upon a determination at the time that it was not more likely than not that the deferred tax assets would be fully realized primarily as a result of the significant operating losses experienced by the Company during 2009 and several years thereafter. For the year ended December 31, 2015, management determined that it was more likely than not that a portion of its deferred tax assets would be realized and released a portion of its valuation allowance in the amount of $95.1 million . In the third quarter of 2016, management determined that it was more likely than not that substantially all of its deferred tax asset would be realized and released substantially all of the remaining valuation allowance, which totaled $60.0 million . ASC 740, Accounting for Income Taxes , paragraph 740-10-30-18, states that four possible sources of taxable income may be available under the tax law to realize a tax benefit for deductible temporary differences. In determining the need for a valuation allowance and in accordance with ASC 740-10-30-17, management evaluated all available evidence, both positive and negative, assessing the objectivity of the evidence and giving more weight to that evidence which is more objective than evidence which is subjective. Positive and negative evidence refers to factors affecting the predictability of one or more of the four sources of taxable income. The positive evidence in the third quarter of 2016 included the fact that the Company had been in a positive cumulative pre-tax income position for the previous three years , and the Company expected to generate taxable income in future years sufficient to absorb substantially all of its net deferred tax assets. A significant component of the Company's deferred tax asset, as of September 30, 2016, related to federal net operating losses ("NOLs") of approximately $300.0 million , which under current law can be carried forward 20 years. Management's estimate of future taxable income is based on internal projections, which consider historical performance, various internal estimates and assumptions, as well as certain external data, all of which, while inherently subject to judgment, management believes to be reasonable. At December 31, 2015, management concluded that the Company did not have sufficient future income to absorb all NOLs and only a portion of the deferred tax asset related to NOLs would be realized, thus releasing only a portion of the valuation allowance. In the third quarter of 2016, as a result of the Merger, management believed the Company had sufficient future income to absorb substantially all of the deferred tax assets, including assets relating to NOLs, and substantially all of the remaining valuation allowance was released. The remaining valuation allowance relates to the deferred tax asset resulting from NOLs in the Commonwealth of Virginia, where Xenith Bankshares, Inc. (the parent company) files a standalone tax return. The parent company is not expected to generate taxable income in future periods; therefore, management has concluded that it is not more likely than not that the deferred tax assets, which is $780 thousand , related to these NOLs will be utilized. If actual results differ significantly from the current estimates of future taxable income, even if caused by adverse macro-economic conditions, the valuation allowance may need to be increased for some or all of the Company's net deferred tax assets. An increase to the deferred tax asset valuation allowance could have a material adverse effect on the Company's financial condition and results of operations.

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Borrowings	Borrowings The Bank has secured borrowing facilities with the FHLB and the FRB. As of March 31, 2017 , total credit availability under the FHLB facility was $818.1 million and a pledged lendable collateral value of $287.8 million . Under this facility, as of March 31, 2017, there were short-term, non-amortizing borrowings outstanding of $50.0 million . Credit availability under the FRB facility as of March 31, 2017 was $141.8 million , which is also based on pledged collateral. At March 31, 2017 , the Bank had no borrowings under the FRB facility. Short-term borrowing sources also include lines of credit with nine banks to borrow federal funds up to $163.0 million on an unsecured basis. The lines are uncommitted and can be canceled by the lender at any time. Three of the lines expire within one year ; the remaining lines have no stated expiration. At March 31, 2017, no amounts were outstanding under these uncommitted lines of credit. Borrowings under these arrangements bear interest at the prevailing Federal Funds Rate. The Company has four placements of trust preferred securities. In all four trusts, the trust issuer has invested the total proceeds from the sale of the trust preferred securities in junior subordinated deferrable interest debentures issued by the Company. The trust preferred securities pay cumulative cash distributions quarterly at an annual rate, which resets quarterly. The Company has fully and unconditionally guaranteed the trust preferred securities through the combined operation of the debentures and other related documents. The Company's obligation under the guarantee is unsecured and subordinate to other senior and subordinated indebtedness. The trust preferred securities are redeemable only at the Company's discretion, subject to regulatory approval. The aggregate carrying value of these debentures as of March 31, 2017 was $30.3 million , The difference between the par amounts and the carrying amounts of the debentures, which is due to purchase accounting adjustments recorded at the acquisition of Gateway Financial Holdings, Inc. in 2008, is being amortized using the interest method as an adjustment to interest expense. Effective interest rates for the trust preferred securities for the period ended March 31, 2017 were between 7.07% and 7.84% . On June 26, 2015, Legacy Xenith issued and sold $8.5 million in aggregate principal amount of its 6.75% subordinated notes due 2025 pursuant to a Subordinated Note Purchase Agreement (the "Subordinated Notes"). The Subordinated Notes, which the Company assumed in the Merger, bear interest at an annual rate of 6.75% , which is payable quarterly in arrears on March 31, June 30, September 30 and December 31. The Subordinated Notes qualify as Tier 2 capital for the Company. As of March 31, 2017 , the carrying value of the Subordinated Notes, including the remaining fair value adjustment recorded at the Merger, was $8.6 million . For the period from the Merger through March 31, 2017, the effective interest rate, including the amortization of the purchase accounting adjustment, on the Subordinated Notes was 6.40% . As of March 31, 2017 , the Company and the Bank, as applicable, were in compliance with all covenants of the Subordinated Notes.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following tables present weighted average basic and diluted shares outstanding and basic and diluted earnings per share for the periods stated. Earnings per share is presented for continuing operations, discontinued operations and total net income attributable to the Company. All stock options were included in the diluted earnings per share calculations for the three months ended March 31, 2017. There were 342,878 stock options not included in the diluted earnings per share calculations for the three months ended March 31, 2016, because their inclusion would have been antidilutive. March 31, 2017 March 31, 2016 Weighted average shares outstanding, basic 23,155,368 17,191,589 Dilutive effect of warrants 61,054 45,292 Dilutive effect of equity awards 191,047 36,692 Dilutive shares 252,101 81,984 Weighted average shares outstanding, diluted 23,407,469 17,273,573 Three Months Ended March 31, 2017 March 31, 2016 Net Income: Net income from continuing operations $ 5,739 $ 1,033 Net (loss) income from discontinued operations (76 ) 349 Net income attributable to Xenith Bankshares $ 5,663 $ 1,382 Basic earnings per share: Earnings per share from continuing operations $ 0.25 $ 0.06 Earnings per share from discontinued operations $ — $ 0.02 Earnings per share attributable to Xenith Bankshares $ 0.24 $ 0.08 Diluted earnings per share: Earnings per share from continuing operations $ 0.25 $ 0.06 Earnings per share from discontinued operations $ — $ 0.02 Earnings per share attributable to Xenith Bankshares $ 0.24 $ 0.08

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies In the ordinary course of operations, the Company has become a party to legal proceedings. Based upon information currently available, management believes that such legal proceedings, in the aggregate, will not have a material adverse effect on the Company's business, financial condition, results of operations or cash flows. In the normal course of business, the Company has commitments under credit agreements to lend to customers as long as there is no material violation of any condition established in the contracts. These commitments generally have fixed expiration dates or other termination clauses and may require payments of fees. Because many of the commitments may expire without being completely drawn upon, the total commitment amounts do not necessarily represent future cash requirements. Additionally, the Company issues letters of credit, which are conditional commitments to guarantee the performance of customers to third parties. The credit risk involved in issuing letters of credit is the same as that involved in extending loans to customers. These commitments represent outstanding off-balance sheet commitments. The following table presents unfunded loan commitments outstanding as of the dates stated: March 31, 2017 December 31, 2016 Commercial lines of credit $ 414,474 $ 372,083 Construction 134,992 113,364 Commercial real estate 35,094 44,790 Residential real estate 91,364 93,981 Consumer 11,124 11,108 Letters of credit 19,213 20,476 Total commitments $ 706,261 $ 655,802

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company classifies financial assets and liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. Valuation methodologies for the fair value hierarchy are as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain U.S. Treasury securities that are highly liquid and are actively traded in over-the-counter markets. Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments and derivative contracts whose values are determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include values that are determined using pricing models, discounted cash flow methodologies, or similar techniques as well as assets and liabilities for which the determination of fair value requires significant management judgment or estimation. The categorization of an asset or liability within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Recurring Basis The Company measures or monitors certain of its assets on a fair value basis. Fair value is used on a recurring basis for those assets and liabilities for which an election was made, as well as for certain assets and liabilities in which fair value is the primary basis of accounting. The following tables present the fair value of assets measured and recognized at fair value on a recurring basis in the consolidated balance sheets as of the dates stated: March 31, 2017 Fair Value Measurements at Reporting Date Using Assets Level 1 Level 2 Level 3 Securities available for sale Mortgage-backed securities Agencies $ 139,454 $ — $ 139,454 $ — Collateralized 61,110 — 61,110 — Collateralized mortgage obligations 18,333 — 18,333 — Asset-backed securities 14,758 — 14,758 — Municipals Tax-exempt 64,361 — 64,361 — Taxable 17,669 — 17,669 — Corporate bonds 981 — 981 — Equity securities 2,075 1,976 — 99 Total securities available for sale 318,741 1,976 316,666 99 Derivative loan commitments — — — — Interest rate swaps 1,213 — 1,213 — Investments in rabbi trust 1,814 1,814 — — Total assets $ 321,768 $ 3,790 $ 317,879 $ 99 Liabilities Interest rate swaps $ 1,138 $ — $ 1,138 $ — Total liabilities $ 1,138 $ — $ 1,138 $ — December 31, 2016 Fair Value Measurements at Reporting Date Using Assets Level 1 Level 2 Level 3 Securities available for sale Mortgage-backed securities Agencies $ 134,890 $ — $ 134,890 $ — Collateralized 62,753 — 62,753 — Collateralized mortgage obligations 19,810 — 19,810 — Asset-backed securities 14,758 — 14,758 — Municipals Tax-exempt 64,755 — 64,755 — Taxable 17,676 — 17,676 — Corporate bonds 984 — 984 — Equity securities 1,817 1,718 — 99 Total securities available for sale 317,443 1,718 315,626 99 Derivative loan commitments 126 — — 126 Interest rate swaps 1,223 — 1,223 — Investments in rabbi trust 1,804 1,804 — — Total assets $ 320,596 $ 3,522 $ 316,849 $ 225 Liabilities Interest rate swaps $ 1,226 $ — $ 1,226 $ — Total liabilities $ 1,226 $ — $ 1,226 $ — The following table presents a rollforward of recurring fair value measurements categorized within Level 3 of the fair value hierarchy for the periods stated: Activity in Level 3 Activity in Level 3 Fair Value Measurements Fair Value Measurements Three Months Ended March 31, 2017 Year Ended December 31, 2016 Investment Derivative Investment Derivative Beginning of period balance $ 99 $ 126 $ 99 $ 1,020 Unrealized gains included in: Earnings — — — — Other comprehensive income — — — — Purchases — — — — Sales — — — — Reclassification from level 3 to level 1 — — — — Issuances — — — 470 Settlements — (126 ) — (1,364 ) End of period balance $ 99 $ — $ 99 $ 126 The Company's policy is to recognize transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. The following describes the valuation techniques used to estimate fair value for assets and liabilities that are measured on a recurring basis. Investment Securities Available for Sale: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models or quoted prices of securities with similar characteristics. Level 2 securities would include U.S. agency securities, mortgage-backed securities, obligations of states and political subdivisions, and certain corporate, asset-backed and other securities valued using third-party quoted prices in markets that are not active. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. Interest Rate Swaps: The Company uses observable inputs to determine fair value of its interest rate swaps. The valuation of these instruments is determined using widely accepted valuation techniques that are based on discounted cash flow analysis using the expected cash flows of each derivative over the contractual terms of the derivatives, including the period to maturity and market-based interest rate curves. The fair value of the interest rate swaps is determined using a market standard methodology of netting the discounted future fixed cash receipts and the discounted expected variable cash payments. The variable cash payments were based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. Accordingly, the Company categorizes these financial instruments within Level 2 of the fair value hierarchy. Investments in Rabbi Trust : Assets held by the Company in the rabbi trust consist of readily-marketable securities where quoted prices are available in active markets and are classified as Level 1 securities. Nonrecurring Basis Certain assets, specifically collateral dependent impaired loans and other real estate owned and repossessed assets, are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment and an allowance is established to adjust the asset to its estimated fair value). The adjustments are based on appraisals of underlying collateral or other observable market prices when current appraisals or observable market prices are available. If an appraisal that is less than 12 months old is not available, an existing appraisal or other valuation would be utilized after adjusting it to reflect current market conditions and, as such, may include significant management assumptions and input with respect to the determination of fair value. The adjustments are based in part upon externally derived statistical data and upon management's knowledge of market conditions and prices of sales of other real estate owned. It is the Company's policy to classify these as Level 3 assets within the fair value hierarchy. Management periodically reviews the adjustments as compared to valuations from updated appraisals and modifies the adjustments accordingly should updated appraisals reflect valuations significantly different than those derived utilizing the adjustments. Management believes the valuations are reasonable for the collateral underlying the loan portfolio; however, while appraisals are indicators of fair value, the amount realized upon the sale of these assets could be significantly different. The following tables present the fair value of assets measured and recognized at fair value on a nonrecurring basis in the consolidated balance sheets as of the dates stated: Assets Fair Value Measurements at March 31, 2017 Using Level 1 Level 2 Level 3 Impaired loans $ 44,453 $ — $ — $ 44,453 Other real estate owned and repossessed assets 5,185 — — 5,185 Assets Fair Value Measurements at December 31, 2016 Using Level 1 Level 2 Level 3 Impaired loans $ 49,378 $ — $ — $ 49,378 Other real estate owned and repossessed assets 5,345 — — 5,345 The following describes the valuation techniques used to estimate fair value for assets that are required to be measured on a nonrecurring basis. Impaired Loans: The majority of the Company's impaired loans are considered collateral dependent. For collateral dependent impaired loans, fair value is measured based upon the estimated fair value of the underlying collateral less costs of disposal or other observable market prices when current appraisals or observable market prices are available. If an appraisal that is less than 12 months old is not available, an existing appraisal or other valuation would be utilized after adjusting it to reflect current market conditions and, as such, may include significant management assumptions and input with respect to the determination of fair value. Other Real Estate Owned and Repossessed Assets: The fair value of other real estate owned and repossessed assets is based primarily on appraisals of the real estate or other observable market prices. The Company's policy is to have current appraisals of these assets; however, if a current appraisal is not available, an existing appraisal would be utilized after adjusting it to reflect changes in market conditions from the date of the existing appraisal and, as such, may include significant management assumptions and input with respect to the determination of fair value. Significant Unobservable Inputs The following table presents the significant unobservable inputs used to value the Company's material Level 3 assets as of the date stated. These factors represent the significant unobservable inputs that were used in measurement of fair value. Significant Unobservable Significant Unobservable Fair Value at Inputs by Inputs as of March 31, 2017 Valuation Technique March 31, 2017 Impaired loans 44,453 Appraised value 9% Average discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell Other real estate owned 5,185 Appraised value 10% Weighted average discounts to reflect current market conditions, abbreviated holding period and estimated costs to sell Other Fair Value Measurements Accounting standards require the disclosure of the estimated fair value of financial instruments that are not recorded at fair value. For the financial instruments that the Company does not record at fair value, estimates of fair value are made at a point in time based on relevant market data and information about the financial instrument. No readily available market exists for a significant portion of the Company's financial instruments. Fair value estimates for these instruments are based on current economic conditions, interest rate risk characteristics and other factors. Many of these estimates involve uncertainties and matters of significant judgment and cannot be determined with precision; therefore, the calculated fair value estimates in many instances cannot be substantiated by comparison to independent markets and, in many cases, may not be realizable in a current sale of the instrument. In addition, changes in assumptions could significantly affect these fair value estimates. The following methods and assumptions were used by the Company in estimating fair value of these financial instruments. Cash and Cash Equivalents: Cash and cash equivalents include cash and due from banks, interest-bearing deposits in other banks, and overnight funds sold and due from FRB. The carrying amount approximates fair value. Investment Securities Available for Sale: Fair values are based on published market prices where available. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flows. Investment securities available for sale are carried at their aggregate fair value. Restricted Equity Securities: These investments are carried at cost. The carrying amount approximates fair value. Loans: To determine the fair values of loans other than those deemed impaired, the Company uses discounted cash flow analyses using discount rates that are similar to the interest rates and terms currently being offered to borrowers of similar terms and credit quality. In valuing acquired loans, the Company also uses valuation techniques that include default rates for similar risk rated loans and estimates of expected cash flows as well as other factors. Interest Receivable and Interest Payable: The carrying amount approximates fair value. Bank-Owned Life Insurance: The carrying amount approximates fair value. Deposits: The fair values disclosed for non-maturity deposits such as demand, including money market, and savings accounts are equal to the amount payable on demand at the reporting date (i.e., carrying values). Fair values for certificates of deposit are estimated using discounted cash flows that applies market interest rates on comparable instruments. Borrowings: The fair value of FHLB borrowings approximates the carrying amount. Other borrowings include the Subordinated Notes and the junior subordinated debentures. The fair value of the Subordinated Notes approximates the carrying value. The fair value of the junior subordinated debentures approximates the par value of the borrowings. Commitments to Extend Credit and Standby Letters of Credit: The only amounts recorded for commitments to extend credit and standby letters of credit are the deferred fees arising from these unrecognized financial instruments. These deferred fees are not deemed significant at March 31, 2017 and December 31, 2016 , and, as such, the related fair values have not been estimated. The following tables present the carrying amounts and fair values of those financial instruments that are not recorded at fair value of have carrying amounts that approximate fair value as of the dates stated: March 31, 2017 Carrying Fair Fair Value Measurements at Reporting Date Using Level 1 Level 2 Level 3 Financial Assets: Loans, net (1) $ 2,338,533 $ 2,348,838 $ — $ — $ 2,348,838 Financial Liabilities: Deposits 2,619,643 2,617,793 — 2,617,793 — FHLB borrowings 50,000 50,000 — 50,000 — Other borrowings 38,938 65,303 — 65,303 — December 31, 2016 Carrying Fair Fair Value Measurements at Reporting Date Using Level 1 Level 2 Level 3 Financial Assets: Loans, net (1) $ 2,442,116 $ 2,448,581 $ — $ — $ 2,448,581 Financial Liabilities: Deposits 2,571,970 2,573,070 — 2,573,070 — FHLB borrowings 172,000 172,000 — 172,000 — Other borrowings 38,813 65,303 — 65,303 — (1) The carrying amount and fair value include impaired loans, and the carrying amount is net of the allowance for loan losses.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Management has evaluated subsequent events through May 10, 2017, which is the date of the consolidated financial statements were available to be issued. There were no subsequent events that required adjustment to or disclosure in the consolidated financial statements.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial reporting and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the financial statements reflect all adjustments (consisting of a normal recurring nature) considered necessary for a fair presentation. The results of operations for the three months ended March 31, 2017 are not necessarily indicative of the results to be expected for the full year. The Company has one banking subsidiary, the Bank, which constitutes substantially all of the Company's assets and operations. Certain comparative balances have been reclassified to reflect current presentation. Any reclassification had no effect on total assets, total shareholders' equity or net income.
Use of Estimates in the Preparation of Financial Statements	The preparation of consolidated financial statements in conformity with GAAP requires management to make assumptions, judgments and estimates that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term are the determination of the allowance for loan losses, the valuation of other real estate owned and repossessed assets, the valuation of net deferred tax assets, the determination of fair value for financial instruments, and the determination of fair values of loans and other assets acquired and liabilities assumed in the Merger.
Recent Accounting Pronouncements	During the second quarter of 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers " ("ASU 2014-09"). ASU 2014-09 represents a comprehensive reform of many of the revenue recognition requirements in GAAP. ASU 2014-09 creates a new topic Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC 606"). ASC 606 will supersede the current revenue recognition requirements in ASC 605, Revenue Recognition , and supersede or amend much of the industry-specific revenue recognition guidance found throughout the ASC. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. ASC 606 creates a five-step process for achieving that core principle: (1) identifying the contract with the customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations; and (5) recognizing revenue when an entity has completed the performance obligations. ASC 606 also requires additional disclosures that allow users of the financial statements to understand the nature, timing and uncertainty of revenue and cash flows resulting from contracts with customers. The effective date of ASC 606 is for the year beginning January 1, 2018. The new revenue standard permits the use of retrospective or cumulative effect transition methods. A majority of the Company's contracts with customers (i.e., financial instruments) do not fall within the scope of ASC 606; therefore, the Company does not expect the adoption of this standard to have a material effect on the Company's consolidated financial statements. In February 2016, the FASB issued ASC Topic 842, Leases ("ASC 842"), which replaces ASC 840, Leases . The core principle of ASC 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in its balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The recognition, measurement and presentation of expenses, and cash flows arising from a lease by a lessee are as follows: For finance leases, a lessee is required to do the following: 1. Recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position; 2. Recognize interest on the lease liability separately from amortization of the right-of-use asset in the statement of comprehensive income; and 3. Classify repayments of principal portion of the lease liability within financing activities and payments of interest on the lease liability and variable lease payments within operating activities in the statement of cash flows. For operating leases, a lessee is required to do the following: 1. Recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, in the statement of financial position; 2. Recognize a single lease cost, calculated so that the cost of the lease is allocated over the lease term on a generally straight-line basis; and 3. Classify all cash payments within operating activities in the statement of cash flows. The effective date for ASC 842 is for annual periods, and interim periods within those annual periods, beginning after December 15, 2018. Early adoption is permitted. The Company is evaluating whether adoption of this standard will have a material effect on the Company's consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting ("ASU 2016-09"), which is intended to improve the accounting for share-based payment transactions as part of the FASB's simplification initiative. ASU 2016-09 changes seven aspects of the accounting for share-based payment award transactions, including: (1) accounting for income taxes; (2) classification of excess tax benefits on the statement of cash flows; (3) forfeitures; (4) minimum statutory tax withholding requirements; (5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes; (6) practical expedient - expected term (nonpublic entities only); and (7) intrinsic value (nonpublic entities only). ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 and interim periods within those years. The implementation of this standard occurred in the current period and did not have a material effect on the Company's consolidated financial statements. In accordance with ASU 2016-09 and beginning in 2017, the Company will recognize excess tax benefits and tax deficiencies as income tax benefit or expense, respectively, in the reporting period in which they occur. Prior to the adoption of this standard, the Company recognized excess tax benefits as capital surplus only when the amounts reduced taxes payable. Additionally, under the updated guidance, the Company will classify excess tax benefits as an operating activity as part of cash payments for taxes on its consolidated statement of cash flows. Under the new guidance, companies are permitted to make an election to account for forfeitures as they occur, rather than estimating forfeitures as of the award's grant date. The Company recognizes forfeitures as they occur, so the new guidance had no effect on the Company's accounting for forfeitures. The Company classifies tax payments made on behalf of employees as cash outflows from financing activities on the statement of cash flows, which results in no change under the new guidance. In June 2016, the FASB issued ASC 326, Measurement of Credit Losses on Financial Instruments ("ASC 326"), which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life. The main objective of ASC 326 is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in ASC 326 replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This standard is effective for annual and interim periods in fiscal years beginning after December 15, 2019. An entity may early adopt the standard for annual and interim periods in fiscal years beginning after December 15, 2018. The Company is evaluating the impact the adoption of this standard will have on the Company's consolidated financial statements. In August 2016, the FASB issued ASC 230, Statement of Cash Flows ("ASC 230"), which is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The guidance addresses: (1) debt prepayment on debt extinguishment costs; (2) settlement of zero-coupon debt instruments; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investments; (7) beneficial interest in securitizations transactions; and (8) separately identifiable cash flows and application of the predominance principle. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017 and interim periods within those years. Early adoption is permitted, including adoption in an interim period. The Company believes the adoption of this standard will not have a material effect on its consolidated statements of cash flows. In October 2016, the FASB issued ASC 740, Income Taxes (Topic 740): Intra-Equity Transfers of Assets Other Than Inventory ("ASC 740"), which requires entities to recognize at the transaction date the income tax consequences of intercompany asset transfers other than inventory. This ASC is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Entities may early adopt the standard, but only at the beginning of an annual period for which no financial statements (interim or annual) have already been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash ("ASU 2016-18"), which requires companies to include cash and cash equivalents that have restrictions on withdrawal or use in total cash and cash equivalents on the statement of cash flows. ASU 2016-18 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted, including adoptions in an interim period. If an entity early adopts the amendments in an interim period, adjustments should be reflected at the beginning of the fiscal year that includes the interim period. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In December 2016, the FASB issued ASU 2016-19, Technical Corrections and Improvements ("ASU 2016-19"), which amends a number of topics in the FASB ASC. The ASU is part of an ongoing FASB project to facilitate ASC updates for non-substantive technical corrections, clarifications and improvements that are not expected to have a significant effect on accounting practice or create a significant administrative cost to most entities. ASU 2016-19 will apply to all reporting entities within the scope of the effected accounting guidance. Most amendments included in ASU 2016-19 were effective upon issuance (December 2016). Certain amendments that require transition guidance are effective for: 1. Public business entities for annual and interim periods in fiscal years beginning after December 2016 (for cloud computing arrangements); and 2. All entities for annual and interim periods in fiscal years beginning after December 15, 2016 (for certain others, including the change to fair value measurement disclosures). Early adoption is permitted for the amendments that require transition guidance. The adoption of this guidance did not have a material effect the Company's consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business ("ASU 2017-01"), which provides a new framework for determining whether transactions should be accounted for as acquisitions or dispositions of assets or businesses. ASU 2017-01 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Entities may early adopt ASU 2017-01 and apply it to transactions that have not been reported in financial statements that have been issued or made available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment ("ASU 2017-04"), which requires an entity to no longer perform a hypothetical purchase price allocation to measure goodwill impairment. Instead, impairment will be measured using the difference between the carrying amount and the fair value of the reporting unit. ASU 2017-04 is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Entities may early adopt the standard for goodwill impairment tests with measurement dates after January 1, 2017. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements. In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), which requires companies to present the service cost component of net benefit cost in the same line items which they report compensation costs. Companies will be required to present all other components of net benefit cost outside of operating income, if this subtotal is presented. ASU 2017-07 is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or make available for issuance. The Company believes the adoption of this standard will not have a material effect on its consolidated financial statements.

Business Combination (Tables)

Business Combination (Tables)	3 Months Ended
	Mar. 31, 2017
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table presents the summary unaudited balance sheet of Legacy Xenith as of the date of the Merger inclusive of the estimated fair value adjustments and the allocation of consideration paid in the Merger to the acquired assets and assumed liabilities. The allocation resulted in goodwill of $26.9 million , which represents the growth opportunities and franchise value the Bank has in the markets it serves. Fair value of assets acquired: Cash and cash equivalents $ 69,241 Securities 139,025 Loans 827,987 Premises and equipment 6,180 Other real estate owned 738 Core deposit intangible 4,006 Accrued interest receivable 4,464 Deferred tax asset 5,156 Bank owned life insurance 19,917 Other assets 17,879 Total assets $ 1,094,593 Fair value of liabilities assumed: Deposits $ 956,078 Accrued interest payable 285 Supplemental executive retirement plan 2,162 Borrowings 36,533 Other liabilities 8,112 Total liabilities $ 1,003,170 Net identifiable assets acquired $ 91,423 Consideration paid: Company's common shares issued (1) 58,915,439 Purchase price per share (2) $ 1.97 Value of common stock issued $ 116,063 Estimated fair value of stock options 2,290 Cash in lieu of fractional shares 1 Total consideration paid 118,354 Goodwill $ 26,931 _______________________ (1) The issuance of shares of common stock in the Merger preceded the Reverse Stock Split and the number of shares of common stock is presented on a pre-Reverse Stock Split basis. (2) The value of the shares of common stock exchanged for shares of Legacy Xenith common stock was based upon the closing price of common stock at July 28, 2016, the last trading day prior to the date of completion of the Merger.
Schedule of Business Acquisitions, Performing and Purchased Impaired Loans Receivable	The following table presents the purchased performing and purchased impaired loans receivable at the date of the Merger and the fair value adjustments recorded immediately following the Merger: Purchased Performing Purchased Impaired Total Principal payments receivable $ 830,613 $ 9,851 $ 840,464 Fair value adjustment - credit and interest (9,318 ) (3,159 ) (12,477 ) Fair value of acquired loans $ 821,295 $ 6,692 $ 827,987
Business Acquisition, Pro Forma Information, Nonrecurring Adjustments	The following table presents, on a pro forma basis, the effect of the Merger for the three months ended March 31, 2016, as if the Merger had occurred at the beginning of 2016. Merger-related costs of $1.6 million incurred in the three months ended March 31, 2016, which are included in the Company's consolidated statements of income, are not included in the pro forma information below. Merger-related costs incurred by Legacy Xenith prior to the completion of the Merger are not included in the Company's consolidated statements of income and are also not included in the pro forma information below. Net income includes pro forma adjustments for the accretion of estimated fair value adjustments (discounts) on acquired loans and amortization of core deposit intangibles. An effective income tax rate of 35% was used in determining pro forma net income. Three Months Ended March 31, 2016 Revenue (net interest income plus noninterest income) $ 26,869 Net income from continuing operations $ 4,304 Earnings per common share (basic and diluted) $ 0.19

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The following table presents summarized operating results of the discontinued operations for the period stated: Three Months Ended March 31, 2017 March 31, 2016 Net interest income $ 19 $ 154 Provision for loan losses (5 ) 26 Net interest income after provision for loan losses 24 128 Noninterest income 140 4,439 Noninterest expense: Salaries and employee benefits 237 3,010 Professional and consultant fees 2 49 Occupancy 5 206 Data processing 40 104 Equipment 2 20 Advertising and marketing 6 220 Other 127 388 Total noninterest expense 419 3,997 Net (loss) income before provision for income taxes (255 ) 570 (Benefit) provision for income taxes (56 ) 15 Net (loss) income (199 ) 555 Net (loss) income attributable to non-controlling interest (123 ) 206 Net (loss) income attributable to Xenith Bankshares, Inc. $ (76 ) $ 349

Investment Securities (Tables)

Investment Securities (Tables)	3 Months Ended
	Mar. 31, 2017
Investments, Debt and Equity Securities [Abstract]
Amortized Cost and Fair Values of Investment Securities Available for Sale	The following table presents amortized cost, gross unrealized gains and losses, and fair values of investment securities available for sale as of the dates stated: March 31, 2017 Gross Gross Unrealized Unrealized Amortized Cost Gains Losses Fair Value Mortgage-backed securities Agencies $ 139,616 $ 736 $ 898 $ 139,454 Collateralized 62,075 61 1,026 61,110 Collateralized mortgage obligations 18,181 259 108 18,332 Asset-backed securities 14,868 — 109 14,759 Municipals Tax-exempt 66,938 — 2,577 64,361 Taxable 18,056 — 387 17,669 Corporate bonds 980 1 — 981 Equity securities 969 1,106 — 2,075 Total securities available for sale $ 321,683 $ 2,163 $ 5,105 $ 318,741 December 31, 2016 Gross Gross Unrealized Unrealized Amortized Cost Gains Losses Fair Value Mortgage-backed securities Agencies $ 135,054 $ 793 $ 957 $ 134,890 Collateralized 63,837 61 1,145 62,753 Collateralized mortgage obligations 19,626 288 104 19,810 Asset-backed securities 14,866 — 108 14,758 Municipals Tax-exempt 67,738 — 2,983 64,755 Taxable 18,105 1 430 17,676 Corporate bonds 983 1 — 984 Equity securities 969 848 — 1,817 Total securities available for sale $ 321,178 $ 1,992 $ 5,727 $ 317,443
Fair Values and Gross Unrealized Losses by Investment	The following tables present the fair values and gross unrealized losses aggregated by investment category and length of time and the number of individual securities that have been in a continuous unrealized loss position as of the dates stated: March 31, 2017 Less than 12 Months 12 Months or More Total Number of Unrealized Unrealized Unrealized Securities Fair Value Loss Fair Value Loss Fair Value Loss Mortgage-backed securities Agencies 36 $ 87,594 $ 893 $ 640 $ 5 $ 88,234 $ 898 Collateralized 20 47,099 1,026 — — 47,099 1,026 Collateralized mortgage obligations 7 7,218 108 — — 7,218 108 Asset-backed securities 6 5,443 64 9,315 45 14,758 109 Municipals Tax-exempt 43 64,361 2,577 — — 64,361 2,577 Taxable 10 17,669 387 — — 17,669 387 Total securities available for sale 122 $ 229,384 $ 5,055 $ 9,955 $ 50 $ 239,339 $ 5,105 December 31, 2016 Less than 12 Months 12 Months or More Total Number of Unrealized Unrealized Unrealized Securities Fair Value Loss Fair Value Loss Fair Value Loss Mortgage-backed securities Agencies 33 $ 88,315 $ 945 $ 695 $ 12 $ 89,010 $ 957 Collateralized 19 42,272 1,145 — — 42,272 1,145 Collateralized mortgage obligations 6 7,216 104 — — 7,216 104 Asset-backed securities 6 5,443 64 9,315 44 14,758 108 Municipals Tax-exempt 44 64,755 2,983 — — 64,755 2,983 Taxable 9 17,149 430 — — 17,149 430 Total securities available for sale 117 $ 225,150 $ 5,671 $ 10,010 $ 56 $ 235,160 $ 5,727
Amortized Cost and Fair Values of Investment Securities not OTTI by Contractual Maturity	The following table presents the amortized cost and fair value by contractual maturity of investment securities available for sale as of the dates stated. Expected maturities may differ from contractual maturities, as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Securities that are not due at a single maturity date and equity securities that do not have contractual maturities are shown separately. March 31, 2017 December 31, 2016 Amortized Amortized Cost Fair Value Cost Fair Value Due in one year or less $ 259 $ 258 $ 502 $ 502 Due after one year but less than five years 12,050 11,850 11,300 11,072 Due after five years but less than ten years 68,556 65,934 69,900 66,880 Due after ten years 4,128 3,988 4,141 3,977 Mortgage-backed securities Agencies 139,616 139,454 135,054 134,890 Collateralized 62,075 61,110 63,837 62,753 Collateralized mortgage obligations 18,181 18,332 19,626 19,810 Corporate Bonds 981 981 983 984 Asset-backed securities 14,868 14,759 14,866 14,758 Equity securities 969 2,075 969 1,817 Total securities available for sale $ 321,683 $ 318,741 $ 321,178 $ 317,443

Loans and Allowance for Loan 27

Loans and Allowance for Loan Losses (Tables)	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Schedule of Loans by Segment	The following table presents the Company's composition of loans as of the dates stated: March 31, 2017 December 31, 2016 Commercial & Industrial $ 787,443 $ 895,952 Construction 255,309 257,712 Commercial real estate 591,739 585,727 Residential real estate 391,971 405,291 Consumer 296,781 274,008 Guaranteed student loans 32,533 44,043 Deferred loan fees and related costs 1,032 1,323 Total loans $ 2,356,808 $ 2,464,056
Schedule of Allowance for Loan Losses	The following table presents the allowance for loan loss activity by loan type for the periods stated: Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 21,940 $ 23,157 Charge-offs: Commercial & Industrial 2,787 258 Construction 55 312 Commercial real estate 720 540 Residential real estate 240 1,603 Consumer 664 19 Guaranteed student loans — — Overdrafts 26 34 Total charge-offs 4,492 2,766 Recoveries: Commercial & Industrial 127 89 Construction 249 268 Commercial real estate 193 222 Residential real estate 221 220 Consumer 28 10 Guaranteed student loans — — Overdrafts — — Total recoveries 818 809 Net charge-offs 3,674 1,957 Provision (benefit) for loan losses 9 (25 ) Balance at end of period $ 18,275 $ 21,175 The following tables present the allowance for loan lease losses, with the amount independently and collectively evaluated for impairment, and loan balances by loan type as of the dates stated: March 31, 2017 Individually Evaluated Collectively Evaluated Total Amount for Impairment for Impairment Allowance for loan losses applicable to: Purchased credit-impaired loans Commercial & Industrial $ — $ — $ — Construction — — — Commercial real estate — — — Residential real estate 9 9 — Consumer — — — Total purchased credit-impaired loans 9 9 — Originated and other purchased loans Commercial & Industrial 4,250 2,324 1,926 Construction 1,130 73 1,057 Commercial real estate 1,747 — 1,747 Residential real estate 4,456 1,445 3,011 Consumer 1,463 40 1,423 Guaranteed student loans — — — Unallocated qualitative 5,220 — 5,220 Total originated and other purchased loans 18,266 3,882 14,384 Total allowance for loan losses $ 18,275 $ 3,891 $ 14,384 Loan balances applicable to: Purchased credit-impaired loans Commercial & Industrial $ 865 $ 865 $ — Construction 978 978 — Commercial real estate 1,050 1,050 — Residential real estate 2,101 2,101 — Consumer 54 54 — Total purchased credit-impaired loans 5,048 5,048 — Originated and other purchased loans Commercial & Industrial 786,578 20,856 765,722 Construction 254,331 7,162 247,169 Commercial real estate 590,689 7,417 583,272 Residential real estate 389,870 12,276 377,594 Consumer 296,727 882 295,845 Guaranteed student loans 32,533 — 32,533 Deferred loan fees and related costs 1,032 — 1,032 Total originated and other purchased loans 2,351,760 48,593 2,303,167 Total loans $ 2,356,808 $ 53,641 $ 2,303,167 December 31, 2016 Individually Evaluated Collectively Evaluated Total Amount for Impairment for Impairment Allowance for loan losses applicable to: Purchased credit-impaired loans Commercial & Industrial $ — $ — $ — Construction — — — Commercial real estate — — — Residential real estate — — — Consumer — — — Total purchased credit-impaired loans — — — Originated and other purchased loans Commercial & Industrial 5,816 3,327 2,489 Construction 1,551 161 1,390 Commercial real estate 2,410 734 1,676 Residential real estate 5,205 1,275 3,930 Consumer 1,967 606 1,361 Guaranteed student loans — — — Unallocated qualitative 4,991 — 4,991 Total originated and other purchased loans 21,940 6,103 15,837 Total allowance for loan losses $ 21,940 $ 6,103 $ 15,837 Loan balances applicable to: Purchased credit-impaired loans Commercial & Industrial $ 897 $ 897 $ — Construction 992 992 — Commercial real estate 1,090 1,090 — Residential real estate 2,122 2,122 — Consumer 55 55 — Total purchased credit-impaired loans 5,156 5,156 — Originated and other purchased loans Commercial & Industrial 895,055 24,052 871,003 Construction 256,720 7,982 248,738 Commercial real estate 584,637 9,184 575,453 Residential real estate 403,169 12,637 390,532 Consumer 273,953 1,551 272,402 Guaranteed student loans 44,043 — 44,043 Deferred loan fees and related costs 1,323 — 1,323 Total originated and other purchased loans 2,458,900 55,406 2,403,494 Total loans $ 2,464,056 $ 60,562 $ 2,403,494
Schedule of Impaired Loans	The following tables present the loans that were individually evaluated for impairment as of the dates and for the periods stated. The tables present those loans with and without an allowance and various additional data. March 31, 2017 Recorded Investment Unpaid Principal Balance Related Allowance With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 865 $ 1,254 $ — Construction 978 1,433 — Commercial real estate 1,050 1,471 — Residential real estate 2,047 2,823 — Consumer 54 90 — Originated and other purchased loans Commercial & Industrial 13,362 14,844 — Construction 6,962 16,370 — Commercial real estate 7,417 10,176 — Residential real estate 6,182 6,874 — Consumer 804 1,342 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — Construction — — — Commercial real estate — — — Residential real estate 54 73 9 Consumer — — — Originated and other purchased loans Commercial & Industrial 7,494 7,494 2,324 Construction 200 200 73 Commercial real estate — — — Residential real estate 6,094 6,094 1,445 Consumer 78 78 40 Total loans individually evaluated for impairment $ 53,641 $ 70,616 $ 3,891 December 31, 2016 Recorded Investment Unpaid Principal Balance Related Allowance With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 897 $ 1,298 $ — Construction 992 1,448 — Commercial real estate 1,090 1,520 — Residential real estate 2,122 2,989 — Consumer 55 92 — Originated and other purchased loans Commercial & Industrial 12,809 14,185 — Construction 7,078 16,327 — Commercial real estate 7,131 9,214 — Residential real estate 7,038 7,816 — Consumer 8 28 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — Construction — — — Commercial real estate — — — Residential real estate — — — Consumer — — — Originated and other purchased loans Commercial & Industrial 11,243 16,297 3,327 Construction 904 1,054 161 Commercial real estate 2,053 2,053 734 Residential real estate 5,599 5,631 1,275 Consumer 1,543 1,546 606 Total loans individually evaluated for impairment $ 60,562 $ 81,498 $ 6,103 Three Months Ended March 31, 2017 2016 Average Recorded Investment Interest Income Recognized Average Recorded Investment Interest Income Recognized With no related allowance recorded: Purchased credit-impaired loans Commercial & Industrial $ 877 $ — $ — $ — Construction 983 — — — Commercial real estate 1,060 — — — Residential real estate 2,054 10 — — Consumer 54 1 — — Originated and other purchased loans Commercial & Industrial 13,733 81 11,995 88 Construction 7,385 71 840 1 Commercial real estate 7,659 65 4,852 17 Residential real estate 6,862 3 5,419 1 Consumer 815 — 15 — With an allowance recorded: Purchased credit-impaired loans Commercial & Industrial — — — — Construction — — — — Commercial real estate — — — — Residential real estate 55 — — — Consumer — — — — Originated and other purchased loans Commercial & Industrial 7,498 48 11,136 49 Construction 214 — 20,075 49 Commercial real estate — — 4,887 49 Residential real estate 6,170 43 6,480 43 Consumer 84 — 88 — Total loans individually evaluated for impairment $ 55,503 $ 322 $ 65,787 $ 297
Schedule of Accretion Activity Related to Acquired Loans	The following table presents accretion of acquired loan discounts for the periods stated. The amount of accretion recognized in the periods is dependent on discounts recorded to reflect acquired loans at their estimated fair values as of the date of the Merger. The amount of accretion recognized within a period is based on many factors, including, among other factors, loan prepayments and curtailments; therefore, amounts recognized are subject to volatility. Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 9,030 $ — Additions — — Accretion (1) (1,015 ) — Disposals (2) (300 ) Balance at end of period $ 7,715 $ — _______________________ (1) Accretion amounts are reported in interest income. (2) Disposals represent the reduction of purchase accounting adjustments (loan discounts) due to the resolution of acquired loans at amounts less than the contractually-owed receivable.
Schedule of Non-Performing Assets	The following table presents nonperforming assets as of the dates stated: March 31, 2017 December 31, 2016 Purchased credit-impaired loans: Commercial & Industrial $ 865 $ 897 Construction 978 992 Commercial real estate 1,050 1,090 Residential real estate 1,656 1,549 Consumer 37 39 Total purchased credit-impaired loans 4,586 4,567 Originated and other purchased loans: Commercial & Industrial 8,682 11,805 Construction 2,109 2,830 Commercial real estate 2,326 3,686 Residential real estate 7,592 7,931 Consumer 883 1,551 Total originated and other purchased loans 21,592 27,803 Total nonaccrual loans 26,178 32,370 Other real estate owned 5,185 5,345 Total nonperforming assets $ 31,363 $ 37,715
Schedule of Non-Accrual and Past Due Loans	The following table presents a reconciliation of nonaccrual loans to impaired loans as of the dates stated: March 31, 2017 December 31, 2016 Nonaccrual loans $ 26,178 $ 32,370 TDRs on accrual 27,001 27,603 Impaired loans on accrual 462 589 Total impaired loans $ 53,641 $ 60,562
Schedule of Rollforward of Non-Accrual Loans	The following table presents a rollforward of nonaccrual loans for the period stated: Commercial & Industrial Construction Commercial real estate Residential real estate Consumer Total Balance at December 31, 2016 $ 12,702 $ 3,822 $ 4,776 $ 9,480 $ 1,590 $ 32,370 Transfers in 3,957 — — 2,103 126 6,186 Transfers to other real estate owned — (19 ) — (105 ) — (124 ) Charge-offs (2,787 ) (55 ) (720 ) (240 ) (690 ) (4,492 ) Payments (3,577 ) (661 ) (183 ) (594 ) (106 ) (5,121 ) Return to accrual (748 ) — (497 ) (1,396 ) — (2,641 ) Loan type reclassification — — — — — — Balance at March 31, 2017 $ 9,547 $ 3,087 $ 3,376 $ 9,248 $ 920 $ 26,178
Age Analysis of Past Due Loans	The following presents an age analysis of loans as of the dates stated: March 31, 2017 30-89 days 90+ days Total Total Current Past Due Past Due Past Due Loans Purchased credit-impaired loans: Commercial & Industrial $ 142 $ — $ 723 $ 723 $ 865 Construction 764 34 180 214 978 Commercial real estate 1,050 — — — 1,050 Residential real estate 1,334 54 713 767 2,101 Consumer 17 — 37 37 54 Total purchased credit-impaired loans 3,307 88 1,653 1,741 5,048 Originated and other purchased loans: Commercial & Industrial 780,470 1,598 4,510 6,108 786,578 Construction 251,988 376 1,967 2,343 254,331 Commercial real estate 586,946 1,417 2,326 3,743 590,689 Residential real estate 380,621 5,733 3,516 9,249 389,870 Consumer 295,853 4 870 874 296,727 Guaranteed student loans 23,495 3,957 5,081 9,038 32,533 Deferred loan fees and related costs 1,032 — — — 1,032 Total originated and other purchased loans 2,320,405 13,085 18,270 31,355 2,351,760 Total loans $ 2,323,712 $ 13,173 $ 19,923 $ 33,096 $ 2,356,808 December 31, 2016 30-89 days 90+ days Total Total Current Past Due Past Due Past Due Loans Purchased credit-impaired loans: Commercial & Industrial $ 145 $ 11 $ 741 $ 752 $ 897 Construction 774 181 37 218 992 Commercial real estate 1,090 — — — 1,090 Residential real estate 1,261 297 564 861 2,122 Consumer 16 — 39 39 55 Total purchased credit-impaired loans 3,286 489 1,381 1,870 5,156 Originated and other purchased loans: Commercial & Industrial 883,531 1,714 9,810 11,524 895,055 Construction 254,058 53 2,609 2,662 256,720 Commercial real estate 580,355 2,911 1,371 4,282 584,637 Residential real estate 395,579 5,124 2,466 7,590 403,169 Consumer 272,147 1,630 176 1,806 273,953 Guaranteed student loans 30,909 5,562 7,572 13,134 44,043 Deferred loan fees and related costs 1,323 — — — 1,323 Total originated and other purchased loans 2,417,902 16,994 24,004 40,998 2,458,900 Total loans $ 2,421,188 $ 17,483 $ 25,385 $ 42,868 $ 2,464,056
Schedule of Credit Quality of Loans	The following tables present information about the credit quality of the loan portfolio using the Company's internal rating system as an indicator as of the dates stated: March 31, 2017 Special Pass Substandard Total Purchased credit-impaired loans: Commercial & Industrial $ — $ — $ 865 $ 865 Construction — — 978 978 Commercial real estate — — 1,050 1,050 Residential real estate — — 2,101 2,101 Consumer — — 54 54 Total purchased credit-impaired loans — — 5,048 5,048 Originated and other purchased loans: Commercial & Industrial 764,411 12,874 9,293 786,578 Construction 245,087 6,766 2,478 254,331 Commercial real estate 579,273 4,022 7,394 590,689 Residential real estate 353,192 22,297 14,381 389,870 Consumer 293,695 2,135 897 296,727 Guaranteed student loans 32,533 — — 32,533 Deferred loan fees and related costs 1,032 — — 1,032 Total originated and other purchased loans 2,269,223 48,094 34,443 2,351,760 Total loans $ 2,269,223 $ 48,094 $ 39,491 $ 2,356,808 December 31, 2016 Special Pass Substandard Total Purchased credit-impaired loans: Commercial & Industrial $ — $ — $ 897 $ 897 Construction — — 992 992 Commercial real estate — — 1,090 1,090 Residential real estate — — 2,122 2,122 Consumer — — 55 55 Total purchased credit-impaired loans — — 5,156 5,156 Originated and other purchased loans: Commercial & Industrial 873,180 9,391 12,484 895,055 Construction 247,335 6,460 2,925 256,720 Commercial real estate 571,781 3,689 9,167 584,637 Residential real estate 366,940 21,646 14,583 403,169 Consumer 270,919 1,467 1,567 273,953 Guaranteed student loans 44,043 — — 44,043 Deferred loan fees and related costs 1,323 — — 1,323 Total originated and other purchased loans 2,375,521 42,653 40,726 2,458,900 Total loans $ 2,375,521 $ 42,653 $ 45,882 $ 2,464,056 The following table presents performing and nonperforming loans identified as TDRs, by loan type, as of the dates stated: March 31, 2017 December 31, 2016 Performing TDRs: Commercial & Industrial $ 12,174 $ 12,247 Construction 5,052 5,152 Commercial real estate 5,091 5,498 Residential real estate 4,684 4,706 Consumer — — Total performing TDRs 27,001 27,603 Nonperforming TDRs: Commercial & Industrial 805 820 Construction 68 73 Commercial real estate — — Residential real estate 285 376 Consumer — — Total nonperforming TDRs 1,158 1,269 Total TDRs $ 28,159 $ 28,872
Loans Classified as TDRs by Management	The following table presents the number of and recorded investment in loans classified as TDRs by management as of the dates stated: March 31, 2017 December 31, 2016 Recorded Recorded Number of Contracts Number of Contracts Commercial & Industrial 13 $ 12,979 13 $ 13,067 Construction 4 5,120 5 5,225 Commercial real estate 6 5,091 7 5,498 Residential real estate 12 4,969 14 5,082 Consumer — — — — Total 35 $ 28,159 39 $ 28,872
Schedule of Accruing and Non-Accruing TDRs	The following table presents a rollforward of accruing and nonaccruing TDRs for the period stated: Accruing Nonaccruing Total Balance at December 31, 2016 $ 27,603 $ 1,269 $ 28,872 Charge-offs — (7 ) (7 ) Payments (602 ) (104 ) (706 ) New TDR designation — — — Release TDR designation — — — Transfer — — — Balance at March 31, 2017 $ 27,001 $ 1,158 $ 28,159

Goodwill and Other Intangible28

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill	The following table presents goodwill and other intangible assets as of the dates stated. March 31, 2017 December 31, 2016 Amortizable core deposit intangible: Gross amount $ 4,006 $ 4,006 Accumulated amortization (350 ) (219 ) Net core deposit intangible $ 3,656 $ 3,787 Goodwill $ 26,931 $ 26,931

Other Real Estate Owned and R29

Other Real Estate Owned and Repossessed Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Other Real Estate Owned and Repossessed Assets [Abstract]
Rollforward Of Other Real Estate Owned	The following table presents a rollforward of other real estate owned and repossessed assets for the period stated: Amount Balance at December 31, 2016 $ 5,345 Transfers in (via foreclosure) 124 Sales (214 ) Gain on sales 6 Impairments (76 ) Balance at March 31, 2017 $ 5,185
Analysis Of The Allowance For Losses On Other Real Estate Owned And Repossessed Assets	The following table presents an analysis of the valuation allowance on these assets for the periods stated: March 31, 2017 March 31, 2016 Balance at beginning of year $ 3,031 $ 9,875 Impairments 76 72 Charge-offs — (2,991 ) Balance at end of period $ 3,107 $ 6,956
Expenses Applicable To Other Real Estate Owned And Repossessed Assets	The following table presents amounts applicable to other real estate owned and repossessed assets included in the consolidated statements of income for the periods stated: Three Months Ended March 31, 2017 2016 (Gain) on sales $ (6 ) $ (249 ) Impairments 76 72 Operating expenses 51 52 Total noninterest expense $ 121 $ (125 )

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Offsetting Assets	The following tables present information about derivatives that are eligible for offset in the consolidated balance sheets as of the dates stated: Gross Net Amounts Gross Amounts Amounts of Assets Not Offset in the Gross Offset in Presented Consolidated Balance Sheets Amounts the in the of Consolidated Consolidated Cash and Security Recognized Balance Balance Financial Collateral Net Assets Sheets Sheets Instruments Received Amount Derivative assets: March 31, 2017 Interest rate swap agreements $ 1,213 $ — $ 1,213 $ 127 $ — $ 1,086 December 31, 2016 Interest rate swap agreements 1,223 — 1,223 53 — 1,170
Offsetting Liabilities	Gross Net Amounts Gross Amounts Amounts of Liabilities Not Offset in the Gross Offset in Presented Consolidated Balance Sheets Amounts the in the of Consolidated Consolidated Cash and Security Recognized Balance Balance Financial Collateral Net Liabilities Sheets Sheets Instruments Requirement Amount Derivative liabilities: March 31, 2017 Interest rate swap agreements $ 1,138 $ — $ 1,138 $ 127 $ 455 $ 556 December 31, 2016 Interest rate swap agreements 1,226 — 1,226 53 341 832

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	The following table presents the federal statutory tax rate reconciled to the Company's effective tax rate from continuing operations for the period stated: Three Months Ended March 31, 2017 Tax Rate Effective tax rate from continuing operations: Income tax at statutory rate $ 2,955 35.00 % Tax-exempt income (294 ) (3.48 )% Nondeductible expenses 6 0.07 % Other 37 0.43 % Income tax provision from continuing operations $ 2,704 32.02 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	March 31, 2017 March 31, 2016 Weighted average shares outstanding, basic 23,155,368 17,191,589 Dilutive effect of warrants 61,054 45,292 Dilutive effect of equity awards 191,047 36,692 Dilutive shares 252,101 81,984 Weighted average shares outstanding, diluted 23,407,469 17,273,573
Schedule Of Basic And Diluted Earnings Per Share Calculations	Three Months Ended March 31, 2017 March 31, 2016 Net Income: Net income from continuing operations $ 5,739 $ 1,033 Net (loss) income from discontinued operations (76 ) 349 Net income attributable to Xenith Bankshares $ 5,663 $ 1,382 Basic earnings per share: Earnings per share from continuing operations $ 0.25 $ 0.06 Earnings per share from discontinued operations $ — $ 0.02 Earnings per share attributable to Xenith Bankshares $ 0.24 $ 0.08 Diluted earnings per share: Earnings per share from continuing operations $ 0.25 $ 0.06 Earnings per share from discontinued operations $ — $ 0.02 Earnings per share attributable to Xenith Bankshares $ 0.24 $ 0.08

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Loan Commitments	The following table presents unfunded loan commitments outstanding as of the dates stated: March 31, 2017 December 31, 2016 Commercial lines of credit $ 414,474 $ 372,083 Construction 134,992 113,364 Commercial real estate 35,094 44,790 Residential real estate 91,364 93,981 Consumer 11,124 11,108 Letters of credit 19,213 20,476 Total commitments $ 706,261 $ 655,802

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value of Assets Measured and Recognized at Fair Value on a Recurring Basis	The following tables present the fair value of assets measured and recognized at fair value on a recurring basis in the consolidated balance sheets as of the dates stated: March 31, 2017 Fair Value Measurements at Reporting Date Using Assets Level 1 Level 2 Level 3 Securities available for sale Mortgage-backed securities Agencies $ 139,454 $ — $ 139,454 $ — Collateralized 61,110 — 61,110 — Collateralized mortgage obligations 18,333 — 18,333 — Asset-backed securities 14,758 — 14,758 — Municipals Tax-exempt 64,361 — 64,361 — Taxable 17,669 — 17,669 — Corporate bonds 981 — 981 — Equity securities 2,075 1,976 — 99 Total securities available for sale 318,741 1,976 316,666 99 Derivative loan commitments — — — — Interest rate swaps 1,213 — 1,213 — Investments in rabbi trust 1,814 1,814 — — Total assets $ 321,768 $ 3,790 $ 317,879 $ 99 Liabilities Interest rate swaps $ 1,138 $ — $ 1,138 $ — Total liabilities $ 1,138 $ — $ 1,138 $ — December 31, 2016 Fair Value Measurements at Reporting Date Using Assets Level 1 Level 2 Level 3 Securities available for sale Mortgage-backed securities Agencies $ 134,890 $ — $ 134,890 $ — Collateralized 62,753 — 62,753 — Collateralized mortgage obligations 19,810 — 19,810 — Asset-backed securities 14,758 — 14,758 — Municipals Tax-exempt 64,755 — 64,755 — Taxable 17,676 — 17,676 — Corporate bonds 984 — 984 — Equity securities 1,817 1,718 — 99 Total securities available for sale 317,443 1,718 315,626 99 Derivative loan commitments 126 — — 126 Interest rate swaps 1,223 — 1,223 — Investments in rabbi trust 1,804 1,804 — — Total assets $ 320,596 $ 3,522 $ 316,849 $ 225 Liabilities Interest rate swaps $ 1,226 $ — $ 1,226 $ — Total liabilities $ 1,226 $ — $ 1,226 $ —
Rollforward of Fair Value by Level and Categorized with Level 3	The following table presents a rollforward of recurring fair value measurements categorized within Level 3 of the fair value hierarchy for the periods stated: Activity in Level 3 Activity in Level 3 Fair Value Measurements Fair Value Measurements Three Months Ended March 31, 2017 Year Ended December 31, 2016 Investment Derivative Investment Derivative Beginning of period balance $ 99 $ 126 $ 99 $ 1,020 Unrealized gains included in: Earnings — — — — Other comprehensive income — — — — Purchases — — — — Sales — — — — Reclassification from level 3 to level 1 — — — — Issuances — — — 470 Settlements — (126 ) — (1,364 ) End of period balance $ 99 $ — $ 99 $ 126
Carrying Amount for Impaired Loans	The following tables present the fair value of assets measured and recognized at fair value on a nonrecurring basis in the consolidated balance sheets as of the dates stated: Assets Fair Value Measurements at March 31, 2017 Using Level 1 Level 2 Level 3 Impaired loans $ 44,453 $ — $ — $ 44,453 Other real estate owned and repossessed assets 5,185 — — 5,185 Assets Fair Value Measurements at December 31, 2016 Using Level 1 Level 2 Level 3 Impaired loans $ 49,378 $ — $ — $ 49,378 Other real estate owned and repossessed assets 5,345 — — 5,345
Carrying Values for Foreclosed Real Estate and Repossessed Assets	The following table presents the significant unobservable inputs used to value the Company's material Level 3 assets as of the date stated. These factors represent the significant unobservable inputs that were used in measurement of fair value. Significant Unobservable Significant Unobservable Fair Value at Inputs by Inputs as of March 31, 2017 Valuation Technique March 31, 2017 Impaired loans 44,453 Appraised value 9% Average discounts to reflect current market conditions, ultimate collectability, and estimated costs to sell Other real estate owned 5,185 Appraised value 10% Weighted average discounts to reflect current market conditions, abbreviated holding period and estimated costs to sell
Schedule of Carrying Amounts and Fair Values Of Those Financial Instruments that are not Recorded at Fair Value	The following tables present the carrying amounts and fair values of those financial instruments that are not recorded at fair value of have carrying amounts that approximate fair value as of the dates stated: March 31, 2017 Carrying Fair Fair Value Measurements at Reporting Date Using Level 1 Level 2 Level 3 Financial Assets: Loans, net (1) $ 2,338,533 $ 2,348,838 $ — $ — $ 2,348,838 Financial Liabilities: Deposits 2,619,643 2,617,793 — 2,617,793 — FHLB borrowings 50,000 50,000 — 50,000 — Other borrowings 38,938 65,303 — 65,303 — December 31, 2016 Carrying Fair Fair Value Measurements at Reporting Date Using Level 1 Level 2 Level 3 Financial Assets: Loans, net (1) $ 2,442,116 $ 2,448,581 $ — $ — $ 2,448,581 Financial Liabilities: Deposits 2,571,970 2,573,070 — 2,573,070 — FHLB borrowings 172,000 172,000 — 172,000 — Other borrowings 38,813 65,303 — 65,303 — (1) The carrying amount and fair value include impaired loans, and the carrying amount is net of the allowance for loan losses.

Basis of Presentation (Details)

Basis of Presentation (Details)	Dec. 07, 2016$ / shares	Mar. 31, 2017branchofficesubsidiary$ / shares	Dec. 31, 2016$ / shares	Jul. 29, 2016$ / sharesshares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of bank branches | branch		42
Number of loan production offices | office		2
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Stock split, conversion ratio	0.1
Number of subsidiary banks | subsidiary		1
Xenith Bankshares, Inc.
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)				$ 0.01
Number of shares issued to shareholders per share of Xenith stock (in shares) | shares				4.4
Xenith Bankshares, Inc. | Legacy Xenith
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)				$ 1

Business Combination - Addition

Business Combination - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2016USD ($)	Jul. 29, 2016USD ($)bank
Business Acquisition [Line Items]
Goodwill	$ 26,931		$ 26,931
Merger-related expenses	$ 250	$ 1,568
Effective income tax rate	32.02%
Xenith Bankshares, Inc.
Business Acquisition [Line Items]
Number of banks in merger | bank				2
Goodwill				$ 26,931
Merger-related expenses		$ 1,600
Effective income tax rate	35.00%

Business Combination - Prelimin

Business Combination - Preliminary Allocation of Consideration Paid (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 29, 2016	Mar. 31, 2017	Dec. 31, 2016
Fair value of liabilities assumed:
Goodwill		$ 26,931	$ 26,931
Xenith Bankshares, Inc.
Fair value of assets acquired:
Cash and cash equivalents	$ 69,241
Securities	139,025
Loans	827,987
Premises and equipment	6,180
Other real estate owned	738
Core deposit intangible	4,006
Accrued interest receivable	4,464
Deferred tax asset	5,156
Bank owned life insurance	19,917
Other assets	17,879
Total assets	1,094,593
Fair value of liabilities assumed:
Deposits	956,078
Accrued interest payable	285
Supplemental executive retirement plan	2,162
Borrowings	36,533
Other liabilities	8,112
Total liabilities	1,003,170
Net identifiable assets acquired	$ 91,423
Company's common shares issued (in shares)	58,915,439
Purchase price per share (in dollars per share)	$ 1.97
Value of common stock issued	$ 116,063
Estimated fair value of stock options	2,290
Cash in lieu of fractional shares	1
Total consideration paid	118,354
Goodwill	$ 26,931

Business Combination - Purchase

Business Combination - Purchased Performing and Impaired Loans Receivable (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Jul. 29, 2016
Purchased Impaired
Business Acquisition [Line Items]
Fair value adjustment - credit and interest	$ (2,100)
Xenith Bankshares, Inc.
Business Acquisition [Line Items]
Principal payments receivable		$ 840,464
Fair value adjustment - credit and interest		(12,477)
Fair value of acquired loans		827,987
Xenith Bankshares, Inc. | Purchased Performing
Business Acquisition [Line Items]
Principal payments receivable		830,613
Fair value adjustment - credit and interest		(9,318)
Fair value of acquired loans		821,295
Xenith Bankshares, Inc. | Purchased Impaired
Business Acquisition [Line Items]
Principal payments receivable		9,851
Fair value adjustment - credit and interest		(3,159)
Fair value of acquired loans		$ 6,692

Business Combination - Schedule

Business Combination - Schedule of Pro Forma Financial Information (Details) - Xenith Bankshares, Inc. $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)$ / shares
Business Acquisition [Line Items]
Revenue (net interest income plus noninterest income) | $	$ 26,869
Net income from continuing operations | $	$ 4,304
Earnings per common share (basic) (in dollars per share) | $ / shares	$ 0.19
Earnings per common share (diluted) (in dollars per share) | $ / shares	$ 0.19

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details) - USD ($)	Oct. 17, 2016	Mar. 31, 2017	Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loans held for sale to investors		$ 0	$ 9,900,000
Liabilities of discontinued operations		579,000	849,000
Discontinued Operations | GMBI
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of business	$ 87,000
Loans held for sale to investors		$ 0	$ 9,900,000

Discontinued Operations - Summa

Discontinued Operations - Summarized Operating Results (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Noninterest expense:
Net (loss) income before provision for income taxes	$ (255)	$ 570
(Benefit) provision for income taxes	(56)	15
Net (loss) income attributable to non-controlling interest	(123)	206
Net (loss) income from discontinued operations	(76)	349
GMBI | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net interest income	19	154
Provision for loan losses	(5)	26
Net interest income after provision for loan losses	24	128
Noninterest income	140	4,439
Noninterest expense:
Salaries and employee benefits	237	3,010
Professional and consultant fees	2	49
Occupancy	5	206
Data processing	40	104
Equipment	2	20
Advertising and marketing	6	220
Other	127	388
Total noninterest expense	419	3,997
Net (loss) income before provision for income taxes	(255)	570
(Benefit) provision for income taxes	(56)	15
Net (loss) income	(199)	555
Net (loss) income attributable to non-controlling interest	(123)	206
Net (loss) income from discontinued operations	$ (76)	$ 349

Cash Reserves (Details)

Cash Reserves (Details) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Cash and Cash Equivalents [Abstract]
Cash reserve requirement, daily average	$ 60.1	$ 63.9

Investment Securities - Amortiz

Investment Securities - Amortized Cost and Fair Values of Investment Securities Available for Sale (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 321,683	$ 321,178
Gross Unrealized Gains	2,163	1,992
Gross Unrealized Losses	5,105	5,727
Fair Value	318,741	317,443
Mortgage-backed securities - Agencies
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	139,616	135,054
Gross Unrealized Gains	736	793
Gross Unrealized Losses	898	957
Fair Value	139,454	134,890
Mortgage-backed securities - Collateralized
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	62,075	63,837
Gross Unrealized Gains	61	61
Gross Unrealized Losses	1,026	1,145
Fair Value	61,110	62,753
Collateralized mortgage obligations
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	18,181	19,626
Gross Unrealized Gains	259	288
Gross Unrealized Losses	108	104
Fair Value	18,332	19,810
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	14,868	14,866
Gross Unrealized Gains	0	0
Gross Unrealized Losses	109	108
Fair Value	14,759	14,758
Municipals - Tax-exempt
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	66,938	67,738
Gross Unrealized Gains	0	0
Gross Unrealized Losses	2,577	2,983
Fair Value	64,361	64,755
Municipals - Taxable
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	18,056	18,105
Gross Unrealized Gains	0	1
Gross Unrealized Losses	387	430
Fair Value	17,669	17,676
Corporate bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	980	983
Gross Unrealized Gains	1	1
Gross Unrealized Losses	0	0
Fair Value	981	984
Equity Securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	969	969
Gross Unrealized Gains	1,106	848
Gross Unrealized Losses	0	0
Fair Value	$ 2,075	$ 1,817

Investment Securities - Additio

Investment Securities - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Available-for-sale securities pledged as collateral	$ 80,100	$ 83,000
Federal Home Loan Bank stock	$ 5,100	10,100
Federal Home Loan Bank annualized dividend rate	4.77%
Federal Reserve Bank Stock	$ 14,000	14,000
Investment in FRB and other restricted stock totaled	$ 178	$ 178

Investment Securities - Fair Va

Investment Securities - Fair Values and Gross Unrealized Losses Aggregated by Investment Category and Length of Time (Details) $ in Thousands	Mar. 31, 2017USD ($)security	Dec. 31, 2016USD ($)security
Securities available for sale:
Number of Securities | security	122	117
Fair Value
Less than 12 Months	$ 229,384	$ 225,150
12 Months or More	9,955	10,010
Total	239,339	235,160
Unrealized Loss
Less than 12 Months	5,055	5,671
12 Months or More	50	56
Total	$ 5,105	$ 5,727
Mortgage-backed securities - Agencies
Securities available for sale:
Number of Securities | security	36	33
Fair Value
Less than 12 Months	$ 87,594	$ 88,315
12 Months or More	640	695
Total	88,234	89,010
Unrealized Loss
Less than 12 Months	893	945
12 Months or More	5	12
Total	$ 898	$ 957
Mortgage-backed securities - Collateralized
Securities available for sale:
Number of Securities | security	20	19
Fair Value
Less than 12 Months	$ 47,099	$ 42,272
12 Months or More	0	0
Total	47,099	42,272
Unrealized Loss
Less than 12 Months	1,026	1,145
12 Months or More	0	0
Total	$ 1,026	$ 1,145
Collateralized mortgage obligations
Securities available for sale:
Number of Securities | security	7	6
Fair Value
Less than 12 Months	$ 7,218	$ 7,216
12 Months or More	0	0
Total	7,218	7,216
Unrealized Loss
Less than 12 Months	108	104
12 Months or More	0	0
Total	$ 108	$ 104
Asset-backed securities
Securities available for sale:
Number of Securities | security	6	6
Fair Value
Less than 12 Months	$ 5,443	$ 5,443
12 Months or More	9,315	9,315
Total	14,758	14,758
Unrealized Loss
Less than 12 Months	64	64
12 Months or More	45	44
Total	$ 109	$ 108
Municipals - Tax-exempt
Securities available for sale:
Number of Securities | security	43	44
Fair Value
Less than 12 Months	$ 64,361	$ 64,755
12 Months or More	0	0
Total	64,361	64,755
Unrealized Loss
Less than 12 Months	2,577	2,983
12 Months or More	0	0
Total	$ 2,577	$ 2,983
Municipals - Taxable
Securities available for sale:
Number of Securities | security	10	9
Fair Value
Less than 12 Months	$ 17,669	$ 17,149
12 Months or More	0	0
Total	17,669	17,149
Unrealized Loss
Less than 12 Months	387	430
12 Months or More	0	0
Total	$ 387	$ 430

Investment Securities - Amort46

Investment Securities - Amortized Cost and Fair Values of Investment Securities not OTTI by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Amortized Cost
Due in one year or less	$ 259	$ 502
Due after one year but less than five years	12,050	11,300
Due after five years but less than ten years	68,556	69,900
Due after ten years	4,128	4,141
Amortized Cost	321,683	321,178
Fair Value
Due in one year or less	258	502
Due after one year but less than five years	11,850	11,072
Due after five years but less than ten years	65,934	66,880
Due after ten years	3,988	3,977
Fair Value	318,741	317,443
Mortgage-backed securities - Agencies
Amortized Cost
Securities	139,616	135,054
Amortized Cost	139,616	135,054
Fair Value
Securities	139,454	134,890
Fair Value	139,454	134,890
Mortgage-backed securities - Collateralized
Amortized Cost
Securities	62,075	63,837
Amortized Cost	62,075	63,837
Fair Value
Securities	61,110	62,753
Fair Value	61,110	62,753
Collateralized mortgage obligations
Amortized Cost
Securities	18,181	19,626
Amortized Cost	18,181	19,626
Fair Value
Securities	18,332	19,810
Fair Value	18,332	19,810
Corporate bonds
Amortized Cost
Securities	981	983
Amortized Cost	980	983
Fair Value
Securities	981	984
Fair Value	981	984
Asset-backed securities
Amortized Cost
Securities	14,868	14,866
Amortized Cost	14,868	14,866
Fair Value
Securities	14,759	14,758
Fair Value	14,759	14,758
Equity Securities
Amortized Cost
Securities	969	969
Amortized Cost	969	969
Fair Value
Securities	2,075	1,817
Fair Value	$ 2,075	$ 1,817

Loans and Allowance for Loan 47

Loans and Allowance for Loan Losses - Additional Information (Details)	3 Months Ended		8 Months Ended	12 Months Ended
	Mar. 31, 2017USD ($)loan	Mar. 31, 2016USD ($)loan	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Jul. 29, 2016USD ($)	Dec. 31, 2015USD ($)
Financing Receivable, Recorded Investment [Line Items]
Gain on sale of loans	$ 19,000	$ 0
Loans pledged as collateral	577,800,000		$ 577,800,000	$ 625,000,000
Adjustment for impairment under ASC 310-30	9,000	(25,000)
Allowance for loan losses	18,275,000	$ 21,175,000	18,275,000	21,940,000		$ 23,157,000
Total impaired loans	53,641,000		53,641,000	60,562,000
Recorded investment with no related allowance	39,700,000		39,700,000	39,200,000
Costs incurred to sales, loans	$ 9,700,000		9,700,000	8,100,000
Minimum period of principal and interest non payment to place under nonaccrual status	90 days
Recorded Investment	$ 28,159,000		28,159,000	28,872,000
Approximate period of nonaccrual status for accrual status consideration	6 months
TDRs returned to accrual status | loan	0
Allowance related to TDRs	$ 3,891,000		3,891,000	6,103,000
TDRs charged off	$ 7,000
Number of loans modified as TDRs | loan	0	0
Commitments related to troubled debt restructurings	$ 0			0
Accruing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	27,001,000		27,001,000	27,603,000
TDRs charged off	0
Non-Accruing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	1,158,000		1,158,000	1,269,000
TDRs charged off	7,000
Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Adjustment for impairment under ASC 310-30			9,000
Loans	5,048,000		5,048,000	5,156,000
Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Fair value adjustment - credit and interest	2,100,000		2,100,000
Recorded Investment	$ 1,158,000		1,158,000	1,269,000
Xenith Bankshares, Inc.
Financing Receivable, Recorded Investment [Line Items]
Fair value adjustment - credit and interest					$ 12,477,000
Principal payments receivable					840,464,000
Xenith Bankshares, Inc. | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Fair value adjustment - credit and interest					3,159,000
Principal payments receivable					$ 9,851,000
Guaranteed student loans
Financing Receivable, Recorded Investment [Line Items]
Guarantee percentage of principal and accrued interest	98.00%
Proceeds from sale of finance receivables	$ 9,900,000
Gain on sale of loans	19,000
Allowance for loan losses	$ 0		0
Period for claim of payment	270 days
Collateral Dependent
Financing Receivable, Recorded Investment [Line Items]
Total impaired loans	$ 43,500,000		43,500,000	50,200,000
Troubled Debt Restructuring
Financing Receivable, Recorded Investment [Line Items]
Allowance related to TDRs	648,000		$ 648,000	$ 705,000
Troubled Debt Restructurings Charged Off
Financing Receivable, Recorded Investment [Line Items]
TDRs charged off	$ 7,000

Loans and Allowance for Loan 48

Loans and Allowance for Loan Losses - Schedule of Loans by Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financing Receivable, Allowance for Credit Losses [Line Items]
Deferred loan fees and related costs	$ 1,032	$ 1,323
Total loans	2,356,808	2,464,056
Commercial & Industrial
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	787,443	895,952
Construction
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	255,309	257,712
Commercial real estate
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	591,739	585,727
Residential real estate
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	391,971	405,291
Consumer
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	296,781	274,008
Guaranteed student loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans, gross	$ 32,533	$ 44,043

Loans and Allowance for Loan 49

Loans and Allowance for Loan Losses - Schedule of Allowance for Loan Losses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Allowance for loan losses:
Balance at beginning of period	$ 21,940,000	$ 23,157,000
Charge-offs	4,492,000	2,766,000
Recoveries	818,000	809,000
Net charge-offs	3,674,000	1,957,000
Provision (benefit) for loan losses	9,000	(25,000)
Balance at end of period	18,275,000	21,175,000
Commercial & Industrial
Allowance for loan losses:
Charge-offs	2,787,000	258,000
Recoveries	127,000	89,000
Construction
Allowance for loan losses:
Charge-offs	55,000	312,000
Recoveries	249,000	268,000
Commercial real estate
Allowance for loan losses:
Charge-offs	720,000	540,000
Recoveries	193,000	222,000
Residential real estate
Allowance for loan losses:
Charge-offs	240,000	1,603,000
Recoveries	221,000	220,000
Consumer
Allowance for loan losses:
Charge-offs	664,000	19,000
Recoveries	28,000	10,000
Guaranteed student loans
Allowance for loan losses:
Charge-offs	0	0
Recoveries	0	0
Balance at end of period	0
Overdrafts
Allowance for loan losses:
Charge-offs	26,000	34,000
Recoveries	$ 0	$ 0

Loans and Allowance for Loan 50

Loans and Allowance for Loan Losses - Independently and Collectively Evaluated for Impairment (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Allowance for loan losses applicable to:
Total Amount	$ 18,275	$ 21,940
Individually Evaluated for Impairment	3,891	6,103
Collectively Evaluated for Impairment	14,384	15,837
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Deferred loan fees and related costs	1,032	1,323
Total loans	2,356,808	2,464,056
Total Loans, Individually Evaluated for Impairment, Net	53,641	60,562
Total Loans, Collectively Evaluated for Impairment, Net	2,303,167	2,403,494
Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	18,266	21,940
Individually Evaluated for Impairment	3,882	6,103
Collectively Evaluated for Impairment	14,384	15,837
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total loans	2,351,760	2,458,900
Total Loans, Individually Evaluated for Impairment, Net	48,593	55,406
Total Loans, Collectively Evaluated for Impairment, Net	2,303,167	2,403,494
Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	9	0
Individually Evaluated for Impairment	9	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	5,048	5,156
Individually Evaluated for Impairment	5,048	5,156
Collectively Evaluated for Impairment	0	0
Commercial & Industrial | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	4,250	5,816
Individually Evaluated for Impairment	2,324	3,327
Collectively Evaluated for Impairment	1,926	2,489
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	786,578	895,055
Individually Evaluated for Impairment	20,856	24,052
Collectively Evaluated for Impairment	765,722	871,003
Commercial & Industrial | Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	0	0
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	865	897
Individually Evaluated for Impairment	865	897
Collectively Evaluated for Impairment	0	0
Construction | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	1,130	1,551
Individually Evaluated for Impairment	73	161
Collectively Evaluated for Impairment	1,057	1,390
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	254,331	256,720
Individually Evaluated for Impairment	7,162	7,982
Collectively Evaluated for Impairment	247,169	248,738
Construction | Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	0	0
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	978	992
Individually Evaluated for Impairment	978	992
Collectively Evaluated for Impairment	0	0
Commercial real estate | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	1,747	2,410
Individually Evaluated for Impairment	0	734
Collectively Evaluated for Impairment	1,747	1,676
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	590,689	584,637
Individually Evaluated for Impairment	7,417	9,184
Collectively Evaluated for Impairment	583,272	575,453
Commercial real estate | Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	0	0
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	1,050	1,090
Individually Evaluated for Impairment	1,050	1,090
Collectively Evaluated for Impairment	0	0
Residential real estate | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	4,456	5,205
Individually Evaluated for Impairment	1,445	1,275
Collectively Evaluated for Impairment	3,011	3,930
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	389,870	403,169
Individually Evaluated for Impairment	12,276	12,637
Collectively Evaluated for Impairment	377,594	390,532
Residential real estate | Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	9	0
Individually Evaluated for Impairment	9	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	2,101	2,122
Individually Evaluated for Impairment	2,101	2,122
Collectively Evaluated for Impairment	0	0
Consumer | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	1,463	1,967
Individually Evaluated for Impairment	40	606
Collectively Evaluated for Impairment	1,423	1,361
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	296,727	273,953
Individually Evaluated for Impairment	882	1,551
Collectively Evaluated for Impairment	295,845	272,402
Consumer | Purchased credit-impaired loans
Allowance for loan losses applicable to:
Total Amount	0	0
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	54	55
Individually Evaluated for Impairment	54	55
Collectively Evaluated for Impairment	0	0
Guaranteed student loans | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	0	0
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	0	0
Loans and Leases Receivable, Net of Deferred Income [Abstract]
Total Amount	32,533	44,043
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	32,533	44,043
Unallocated qualitative | Originated and other purchased loans
Allowance for loan losses applicable to:
Total Amount	5,220	4,991
Individually Evaluated for Impairment	0	0
Collectively Evaluated for Impairment	$ 5,220	$ 4,991

Loans and Allowance for Loan 51

Loans and Allowance for Loan Losses - Schedule of Impaired Loans by Type, With and Without Allowance (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Recorded Investment
With no related allowance recorded	$ 39,700	$ 39,200
Total impaired loans	53,641	60,562
Unpaid Principal Balance
Total	70,616	81,498
Related Allowance	3,891	6,103
Commercial & Industrial | Originated and other purchased loans
Recorded Investment
With no related allowance recorded	13,362	12,809
With an allowance recorded	7,494	11,243
Unpaid Principal Balance
With no related allowance recorded	14,844	14,185
With an allowance recorded	7,494	16,297
Related Allowance	2,324	3,327
Commercial & Industrial | Purchased credit-impaired loans
Recorded Investment
With no related allowance recorded	865	897
With an allowance recorded	0	0
Unpaid Principal Balance
With no related allowance recorded	1,254	1,298
With an allowance recorded	0	0
Related Allowance	0	0
Construction | Originated and other purchased loans
Recorded Investment
With no related allowance recorded	6,962	7,078
With an allowance recorded	200	904
Unpaid Principal Balance
With no related allowance recorded	16,370	16,327
With an allowance recorded	200	1,054
Related Allowance	73	161
Construction | Purchased credit-impaired loans
Recorded Investment
With no related allowance recorded	978	992
With an allowance recorded	0	0
Unpaid Principal Balance
With no related allowance recorded	1,433	1,448
With an allowance recorded	0	0
Related Allowance	0	0
Commercial real estate | Originated and other purchased loans
Recorded Investment
With no related allowance recorded	7,417	7,131
With an allowance recorded	0	2,053
Unpaid Principal Balance
With no related allowance recorded	10,176	9,214
With an allowance recorded	0	2,053
Related Allowance	0	734
Commercial real estate | Purchased credit-impaired loans
Recorded Investment
With no related allowance recorded	1,050	1,090
With an allowance recorded	0	0
Unpaid Principal Balance
With no related allowance recorded	1,471	1,520
With an allowance recorded	0	0
Related Allowance	0	0
Residential real estate | Originated and other purchased loans
Recorded Investment
With no related allowance recorded	6,182	7,038
With an allowance recorded	6,094	5,599
Unpaid Principal Balance
With no related allowance recorded	6,874	7,816
With an allowance recorded	6,094	5,631
Related Allowance	1,445	1,275
Residential real estate | Purchased credit-impaired loans
Recorded Investment
With no related allowance recorded	2,047	2,122
With an allowance recorded	54	0
Unpaid Principal Balance
With no related allowance recorded	2,823	2,989
With an allowance recorded	73	0
Related Allowance	9	0
Consumer | Originated and other purchased loans
Recorded Investment
With no related allowance recorded	804	8
With an allowance recorded	78	1,543
Unpaid Principal Balance
With no related allowance recorded	1,342	28
With an allowance recorded	78	1,546
Related Allowance	40	606
Consumer | Purchased credit-impaired loans
Recorded Investment
With no related allowance recorded	54	55
With an allowance recorded	0	0
Unpaid Principal Balance
With no related allowance recorded	90	92
With an allowance recorded	0	0
Related Allowance	$ 0	$ 0

Loans and Allowance for Loan 52

Loans and Allowance for Loan Losses - Impaired Loans Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Average Recorded Investment
Total loans individually evaluated for impairment	$ 55,503	$ 65,787
Interest Income Recognized
Total loans individually evaluated for impairment	322	297
Commercial & Industrial | Originated and other purchased loans
Average Recorded Investment
With no related allowance recorded	13,733	11,995
With an allowance recorded	7,498	11,136
Interest Income Recognized
With no related allowance recorded	81	88
With an allowance recorded	48	49
Commercial & Industrial | Purchased credit-impaired loans
Average Recorded Investment
With no related allowance recorded	877	0
With an allowance recorded	0	0
Interest Income Recognized
With no related allowance recorded	0	0
With an allowance recorded	0	0
Construction | Originated and other purchased loans
Average Recorded Investment
With no related allowance recorded	7,385	840
With an allowance recorded	214	20,075
Interest Income Recognized
With no related allowance recorded	71	1
With an allowance recorded	0	49
Construction | Purchased credit-impaired loans
Average Recorded Investment
With no related allowance recorded	983	0
With an allowance recorded	0	0
Interest Income Recognized
With no related allowance recorded	0	0
With an allowance recorded	0	0
Commercial real estate | Originated and other purchased loans
Average Recorded Investment
With no related allowance recorded	7,659	4,852
With an allowance recorded	0	4,887
Interest Income Recognized
With no related allowance recorded	65	17
With an allowance recorded	0	49
Commercial real estate | Purchased credit-impaired loans
Average Recorded Investment
With no related allowance recorded	1,060	0
With an allowance recorded	0	0
Interest Income Recognized
With no related allowance recorded	0	0
With an allowance recorded	0	0
Residential real estate | Originated and other purchased loans
Average Recorded Investment
With no related allowance recorded	6,862	5,419
With an allowance recorded	6,170	6,480
Interest Income Recognized
With no related allowance recorded	3	1
With an allowance recorded	43	43
Residential real estate | Purchased credit-impaired loans
Average Recorded Investment
With no related allowance recorded	2,054	0
With an allowance recorded	55	0
Interest Income Recognized
With no related allowance recorded	10	0
With an allowance recorded	0	0
Consumer | Originated and other purchased loans
Average Recorded Investment
With no related allowance recorded	815	15
With an allowance recorded	84	88
Interest Income Recognized
With no related allowance recorded	0	0
With an allowance recorded	0	0
Consumer | Purchased credit-impaired loans
Average Recorded Investment
With no related allowance recorded	54	0
With an allowance recorded	0	0
Interest Income Recognized
With no related allowance recorded	1	0
With an allowance recorded	$ 0	$ 0

Loans and Allowance for Loan 53

Loans and Allowance for Loan Losses - Accretion Activity Related to Acquired Loans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Balance at beginning of period	$ 9,030	$ 0
Additions	0	0
Accretion	(1,015)	0
Disposals	(300)
Balance at end of period	$ 7,715	$ 0

Loans and Allowance for Loan 54

Loans and Allowance for Loan Losses - Schedule of Non-Performing Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	$ 26,178	$ 32,370
Other real estate owned and repossessed assets	5,185	5,345
Non-performing assets	31,363	37,715
Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	21,592	27,803
Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	4,586	4,567
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	9,547	12,702
Commercial & Industrial | Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	8,682	11,805
Commercial & Industrial | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	865	897
Construction
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	3,087	3,822
Construction | Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	2,109	2,830
Construction | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	978	992
Commercial real estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	3,376	4,776
Commercial real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	2,326	3,686
Commercial real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	1,050	1,090
Residential real estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	9,248	9,480
Residential real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	7,592	7,931
Residential real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	1,656	1,549
Consumer
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	920	1,590
Consumer | Originated and other purchased loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	883	1,551
Consumer | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans	$ 37	$ 39

Loans and Allowance for Loan 55

Loans and Allowance for Loan Losses - Schedule of Non-Accrual and Past Due Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Receivables [Abstract]
Nonaccrual loans	$ 26,178	$ 32,370
TDRs on accrual	27,001	27,603
Impaired loans on accrual	462	589
Total impaired loans	$ 53,641	$ 60,562

Loans and Allowance for Loan 56

Loans and Allowance for Loan Losses - Rollforward of Non-Accrual Loans (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	$ 32,370
Transfers in	6,186
Transfers to other real estate owned	(124)
Charge-offs	(4,492)
Payments	(5,121)
Return to accrual	(2,641)
Loan type reclassification	0
Ending Balance	26,178
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	12,702
Transfers in	3,957
Transfers to other real estate owned	0
Charge-offs	(2,787)
Payments	(3,577)
Return to accrual	(748)
Loan type reclassification	0
Ending Balance	9,547
Construction
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	3,822
Transfers in	0
Transfers to other real estate owned	(19)
Charge-offs	(55)
Payments	(661)
Return to accrual	0
Loan type reclassification	0
Ending Balance	3,087
Commercial real estate
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	4,776
Transfers in	0
Transfers to other real estate owned	0
Charge-offs	(720)
Payments	(183)
Return to accrual	(497)
Loan type reclassification	0
Ending Balance	3,376
Residential real estate
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	9,480
Transfers in	2,103
Transfers to other real estate owned	(105)
Charge-offs	(240)
Payments	(594)
Return to accrual	(1,396)
Loan type reclassification	0
Ending Balance	9,248
Consumer
Financing Receivable, Recorded Investment, Past Due [Roll Forward]
Beginning Balance	1,590
Transfers in	126
Transfers to other real estate owned	0
Charge-offs	(690)
Payments	(106)
Return to accrual	0
Loan type reclassification	0
Ending Balance	$ 920

Loans and Allowance for Loan 57

Loans and Allowance for Loan Losses - Age Analysis of Past Due Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financing Receivable, Recorded Investment, Aging [Abstract]
Deferred loan fees and related costs	$ 1,032	$ 1,323
Total loans, current, net of deferred loan fees and related costs	2,323,712	2,421,188
Total loans, past due, net of deferred loan fees and related costs	33,096	42,868
Total loans	2,356,808	2,464,056
Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Total loans, current, net of deferred loan fees and related costs	2,320,405	2,417,902
Total loans, past due, net of deferred loan fees and related costs	31,355	40,998
Total loans	2,351,760	2,458,900
Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	3,307	3,286
Past Due	1,741	1,870
Total Loans	5,048	5,156
30 To 89 days Past Due
Financing Receivable, Recorded Investment, Aging [Abstract]
Total loans, past due, net of deferred loan fees and related costs	13,173	17,483
30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Total loans, past due, net of deferred loan fees and related costs	13,085	16,994
30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	88	489
90-Plus Days Past Due
Financing Receivable, Recorded Investment, Aging [Abstract]
Total loans, past due, net of deferred loan fees and related costs	19,923	25,385
90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Total loans, past due, net of deferred loan fees and related costs	18,270	24,004
90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	1,653	1,381
Commercial & Industrial
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	787,443	895,952
Commercial & Industrial | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	780,470	883,531
Past Due	6,108	11,524
Total Loans	786,578	895,055
Commercial & Industrial | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	142	145
Past Due	723	752
Total Loans	865	897
Commercial & Industrial | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	1,598	1,714
Commercial & Industrial | 30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	0	11
Commercial & Industrial | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	4,510	9,810
Commercial & Industrial | 90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	723	741
Construction
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	255,309	257,712
Construction | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	251,988	254,058
Past Due	2,343	2,662
Total Loans	254,331	256,720
Construction | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	764	774
Past Due	214	218
Total Loans	978	992
Construction | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	376	53
Construction | 30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	34	181
Construction | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	1,967	2,609
Construction | 90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	180	37
Commercial real estate
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	591,739	585,727
Commercial real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	586,946	580,355
Past Due	3,743	4,282
Total Loans	590,689	584,637
Commercial real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	1,050	1,090
Past Due	0	0
Total Loans	1,050	1,090
Commercial real estate | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	1,417	2,911
Commercial real estate | 30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	0	0
Commercial real estate | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	2,326	1,371
Commercial real estate | 90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	0	0
Residential real estate
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	391,971	405,291
Residential real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	380,621	395,579
Past Due	9,249	7,590
Total Loans	389,870	403,169
Residential real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	1,334	1,261
Past Due	767	861
Total Loans	2,101	2,122
Residential real estate | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	5,733	5,124
Residential real estate | 30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	54	297
Residential real estate | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	3,516	2,466
Residential real estate | 90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	713	564
Consumer
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	296,781	274,008
Consumer | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	295,853	272,147
Past Due	874	1,806
Total Loans	296,727	273,953
Consumer | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	17	16
Past Due	37	39
Total Loans	54	55
Consumer | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	4	1,630
Consumer | 30 To 89 days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	0	0
Consumer | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	870	176
Consumer | 90-Plus Days Past Due | Purchased credit-impaired loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	37	39
Guaranteed student loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Loans	32,533	44,043
Guaranteed student loans | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Current	23,495	30,909
Past Due	9,038	13,134
Total Loans	32,533	44,043
Guaranteed student loans | 30 To 89 days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	3,957	5,562
Guaranteed student loans | 90-Plus Days Past Due | Originated and other purchased loans
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	$ 5,081	$ 7,572

Loans and Allowance for Loan 58

Loans and Allowance for Loan Losses - Schedule of Credit Quality of Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financing Receivable, Recorded Investment [Line Items]
Deferred loan fees and related costs	$ 1,032	$ 1,323
Total loans	2,356,808	2,464,056
Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,351,760	2,458,900
Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	5,048	5,156
Pass
Financing Receivable, Recorded Investment [Line Items]
Deferred loan fees and related costs	1,032	1,323
Total loans	2,269,223	2,375,521
Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,269,223	2,375,521
Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Special Mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	48,094	42,653
Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	48,094	42,653
Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	39,491	45,882
Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	34,443	40,726
Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	5,048	5,156
Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	787,443	895,952
Commercial & Industrial | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	786,578	895,055
Commercial & Industrial | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	865	897
Commercial & Industrial | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	764,411	873,180
Commercial & Industrial | Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Commercial & Industrial | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	12,874	9,391
Commercial & Industrial | Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Commercial & Industrial | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	9,293	12,484
Commercial & Industrial | Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	865	897
Construction
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	255,309	257,712
Construction | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	254,331	256,720
Construction | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	978	992
Construction | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	245,087	247,335
Construction | Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Construction | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	6,766	6,460
Construction | Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Construction | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	2,478	2,925
Construction | Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	978	992
Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	591,739	585,727
Commercial real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	590,689	584,637
Commercial real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	1,050	1,090
Commercial real estate | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	579,273	571,781
Commercial real estate | Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Commercial real estate | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	4,022	3,689
Commercial real estate | Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Commercial real estate | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	7,394	9,167
Commercial real estate | Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	1,050	1,090
Residential real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	391,971	405,291
Residential real estate | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	389,870	403,169
Residential real estate | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	2,101	2,122
Residential real estate | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	353,192	366,940
Residential real estate | Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Residential real estate | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	22,297	21,646
Residential real estate | Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Residential real estate | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	14,381	14,583
Residential real estate | Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	2,101	2,122
Consumer
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	296,781	274,008
Consumer | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	296,727	273,953
Consumer | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	54	55
Consumer | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	293,695	270,919
Consumer | Pass | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Consumer | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	2,135	1,467
Consumer | Special Mention | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Consumer | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	897	1,567
Consumer | Substandard | Purchased credit-impaired loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	54	55
Guaranteed student loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	32,533	44,043
Guaranteed student loans | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	32,533	44,043
Guaranteed student loans | Pass | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	32,533	44,043
Guaranteed student loans | Special Mention | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	0	0
Guaranteed student loans | Substandard | Originated and other purchased loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, gross	$ 0	$ 0

Loans and Allowance for Loan 59

Loans and Allowance for Loan Losses - Loans Classified as TDRs by Management (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017USD ($)contract	Dec. 31, 2016USD ($)contract
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	35	39
Recorded Investment | $	$ 28,159	$ 28,872
Commercial & Industrial
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	13	13
Recorded Investment | $	$ 12,979	$ 13,067
Construction
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	4	5
Recorded Investment | $	$ 5,120	$ 5,225
Commercial real estate
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	6	7
Recorded Investment | $	$ 5,091	$ 5,498
Residential real estate
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	12	14
Recorded Investment | $	$ 4,969	$ 5,082
Consumer
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	0	0
Recorded Investment | $	$ 0	$ 0

Loans and Allowance for Loan 60

Loans and Allowance for Loan Losses - Rollforward of Accruing and Nonaccruing TDRs (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)
Financing Receivable Modifications [Roll Forward]
Balance at December 31, 2016	$ 28,872
Charge-offs	(7)
Payments	(706)
New TDR designation	0
Release TDR designation	0
Transfer	0
Balance at March 31, 2017	28,159
Accruing
Financing Receivable Modifications [Roll Forward]
Balance at December 31, 2016	27,603
Charge-offs	0
Payments	(602)
New TDR designation	0
Release TDR designation	0
Transfer	0
Balance at March 31, 2017	27,001
Non-Accruing
Financing Receivable Modifications [Roll Forward]
Balance at December 31, 2016	1,269
Charge-offs	(7)
Payments	(104)
New TDR designation	0
Release TDR designation	0
Transfer	0
Balance at March 31, 2017	$ 1,158

Loans and Allowance for Loan 61

Loans and Allowance for Loan Losses - Schedule of Performing and Nonperforming TDRs (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	$ 28,159	$ 28,872
Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	27,001	27,603
Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	1,158	1,269
Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	12,979	13,067
Commercial & Industrial | Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	12,174	12,247
Commercial & Industrial | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	805	820
Construction
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	5,120	5,225
Construction | Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	5,052	5,152
Construction | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	68	73
Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	5,091	5,498
Commercial real estate | Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	5,091	5,498
Commercial real estate | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	0	0
Residential real estate
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	4,969	5,082
Residential real estate | Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	4,684	4,706
Residential real estate | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	285	376
Consumer
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	0	0
Consumer | Purchased Performing
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	0	0
Consumer | Purchased Impaired
Financing Receivable, Recorded Investment [Line Items]
Recorded Investment	$ 0	$ 0

Goodwill and Other Intangible62

Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	Jul. 29, 2016	Mar. 31, 2017	Dec. 31, 2016
Business Acquisition [Line Items]
Goodwill		$ 26,931	$ 26,931
Xenith Bankshares, Inc.
Business Acquisition [Line Items]
Goodwill	$ 26,931
Core deposit intangible	4,006
Xenith Bankshares, Inc. | Core Deposits
Business Acquisition [Line Items]
Core deposit intangible	$ 4,000
Core deposit amortization period	8 years

Goodwill and Other Intangible63

Goodwill and Other Intangible Assets - Schedule of Goodwill and Other Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Amortizable core deposit intangible:
Net core deposit intangible	$ 3,656	$ 3,787
Goodwill	26,931	26,931
Core Deposits
Amortizable core deposit intangible:
Gross amount	4,006	4,006
Accumulated amortization	(350)	(219)
Net core deposit intangible	$ 3,656	$ 3,787

Other Real Estate Owned and R64

Other Real Estate Owned and Repossessed Assets - Rollforward of Other Real Estate Owned and Repossessed Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Other Real Estate Owned And Repossessed Assets [Roll Forward]
Balance at December 31, 2016	$ 5,345
Transfers in (via foreclosure)	124
Sales	(214)
Gain on sales	6	$ 249
Impairments	(76)	$ (72)
Balance at March 31, 2017	$ 5,185

Other Real Estate Owned and R65

Other Real Estate Owned and Repossessed Assets - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Mortgage Loans on Real Estate [Line Items]
Other real estate	$ 5,185	$ 5,345
Residential Mortgage
Mortgage Loans on Real Estate [Line Items]
Other real estate	129
Mortgage loans in process of foreclosure	$ 407

Other Real Estate Owned and R66

Other Real Estate Owned and Repossessed Assets - Presented Net of Allowance for Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Real Estate Owned Valuation Allowance [Roll Forward]
Balance at beginning of year	$ 3,031	$ 9,875
Impairments	76	72
Charge-offs	0	(2,991)
Balance at end of period	$ 3,107	$ 6,956

Other Real Estate Owned and R67

Other Real Estate Owned and Repossessed Assets - Expenses Applicable to Other Real Estate Owned and Repossessed Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Other Real Estate Owned and Repossessed Assets [Abstract]
(Gain) on sales	$ (6)	$ (249)
Impairments	76	72
Operating expenses	51	52
Total noninterest expense	$ 121	$ (125)

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Schedule of Trading Securities and Other Trading Assets [Line Items]
Period of interest rate lock	60 days
Residential mortgage loans held for sale	$ 0		$ 9,900
Residential mortgage loans	0		$ 1,400
Interest rate swap agreements
Schedule of Trading Securities and Other Trading Assets [Line Items]
Gain related to trading income	133	$ 110
Interest rate swap agreements
Schedule of Trading Securities and Other Trading Assets [Line Items]
Collateral pledged under agreements	$ 6,300

Derivative Instruments - Financ

Derivative Instruments - Financial Instruments Eligible for Offset, Assets (Details) - Interest rate swap agreements - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Derivative assets:
Gross Amounts of Recognized Assets	$ 1,213	$ 1,223
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Assets Presented in the Consolidated Balance Sheets	1,213	1,223
Gross Amounts Not Offset in the Consolidated Balance Sheets, Financial Instruments	127	53
Collateral pledged under agreements	0	0
Net Amount	$ 1,086	$ 1,170

Derivative Instruments - Fina70

Derivative Instruments - Financial Instruments Eligible for Offset, Liabilities (Details) - Interest rate swap agreements - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	$ 1,138	$ 1,226
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets	1,138	1,226
Gross Amounts Not Offset in the Consolidated Balance Sheets, Financial Instruments	127	53
Gross Amounts Not Offset in the Consolidated Balance Sheets, Cash and Security Collateral Requirement	455	341
Net Amount	$ 556	$ 832

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Tax
Income tax at statutory rate	$ 2,955
Tax-exempt income	(294)
Nondeductible expenses	6
Other	37
Income tax provision from continuing operations	$ 2,704	$ 734
Rate
Income tax at statutory rate	35.00%
Tax-exempt income	(3.48%)
Nondeductible expenses	0.07%
Other	0.43%
Income tax provision from continuing operations	32.02%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Deferred tax assets, net			$ 154,900
Deferred tax assets, valuation allowance			$ 780
Reversal of valuation allowance	$ 60,000	$ 95,100
Deferred tax asset, valuation allowance lookback period	3 years
Deferred tax asset, net operating loss carryforward	$ 300,000

Borrowings (Details)

Borrowings (Details)	3 Months Ended
	Mar. 31, 2017USD ($)banktrustcredit_facility	Dec. 31, 2016USD ($)	Jun. 26, 2015USD ($)
Debt Instrument [Line Items]
FHLB maximum amount available	$ 818,100,000
Collateral amount	287,800,000
Federal Home Loan Bank borrowings	$ 50,000,000	$ 172,000,000
Mandatorily Redeemable Preferred Stock
Debt Instrument [Line Items]
Number of trust preferred securities | trust	4
Carrying value of debentures	$ 30,300,000
Mandatorily Redeemable Preferred Stock | Minimum
Debt Instrument [Line Items]
Effective interest rate percentage	7.07%
Mandatorily Redeemable Preferred Stock | Maximum
Debt Instrument [Line Items]
Effective interest rate percentage	7.84%
6.75% Subordinated Notes Due 2025 | Subordinated Debt
Debt Instrument [Line Items]
Effective interest rate percentage	6.40%
Debt, face amount			$ 8,500,000
Stated interest rate percentage			6.75%
Debt outstanding	$ 8,600,000
Federal Reserve Bank Advances | FRB Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	141,800,000
Short-term debt	0
Federal Funds Purchased
Debt Instrument [Line Items]
Maximum borrowing capacity	163,000,000
Short-term debt	$ 0
Number of bank lenders | bank	9
Number of lines of credit with expiration period | credit_facility	3
Expiration period	1 year

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details)	3 Months Ended
	Mar. 31, 2016shares
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive stock options not included in diluted EPS (in shares)	342,878

Earnings Per Share - Schedule D

Earnings Per Share - Schedule Dilutive Weighted Average Shares (Details) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Earnings Per Share [Abstract]
Weighted average number of common shares outstanding (in shares)	23,155,368	17,191,589
Dilutive effect of warrants (in shares)	61,054	45,292
Dilutive effect of equity awards (in shares)	191,047	36,692
Total dilutive effect (in shares)	252,101	81,984
Diluted weighted average number of common shares outstanding (in shares)	23,407,469	17,273,573

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net Income:
Net income from continuing operations	$ 5,739	$ 1,033
Net income from discontinued operations	(76)	349
Net income attributable to Xenith Bankshares, Inc.	$ 5,663	$ 1,382
Basic earnings per share:
Earnings per share from continuing operations (in dollars per share)	$ 0.25	$ 0.06
Earnings per share from discontinued operations (in dollars per share)	0	0.02
Earnings per share attributable to Xenith Bankshares (in dollars per share)	0.24	0.08
Diluted earnings per share:
Earnings per share from continuing operations (in dollars per share)	0.25	0.06
Earnings per share from discontinued operations (in dollars per share)	0	0.02
Earnings per share attributable to Xenith Bankshares (in dollars per share)	$ 0.24	$ 0.08

Commitments and Contingencies77

Commitments and Contingencies (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Other Commitments [Line Items]
Total commitments	$ 706,261	$ 655,802
Unfunded loan commitments | Commercial & Industrial
Other Commitments [Line Items]
Total commitments	414,474	372,083
Unfunded loan commitments | Construction
Other Commitments [Line Items]
Total commitments	134,992	113,364
Unfunded loan commitments | Commercial real estate
Other Commitments [Line Items]
Total commitments	35,094	44,790
Unfunded loan commitments | Residential real estate
Other Commitments [Line Items]
Total commitments	91,364	93,981
Unfunded loan commitments | Consumer
Other Commitments [Line Items]
Total commitments	11,124	11,108
Letters of credit
Other Commitments [Line Items]
Total commitments	$ 19,213	$ 20,476

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Assets Measured and Recognized at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Investment securities available for sale:
Investment securities available for sale, at fair value	$ 318,741	$ 317,443
Mortgage-backed securities - Agencies
Investment securities available for sale:
Investment securities available for sale, at fair value	139,454	134,890
Mortgage-backed securities - Collateralized
Investment securities available for sale:
Investment securities available for sale, at fair value	61,110	62,753
Collateralized mortgage obligations
Investment securities available for sale:
Investment securities available for sale, at fair value	18,332	19,810
Asset-backed securities
Investment securities available for sale:
Investment securities available for sale, at fair value	14,759	14,758
Municipals - Tax-exempt
Investment securities available for sale:
Investment securities available for sale, at fair value	64,361	64,755
Municipals - Taxable
Investment securities available for sale:
Investment securities available for sale, at fair value	17,669	17,676
Corporate bonds
Investment securities available for sale:
Investment securities available for sale, at fair value	981	984
Equity Securities
Investment securities available for sale:
Investment securities available for sale, at fair value	2,075	1,817
Recurring
Investment securities available for sale:
Investment securities available for sale, at fair value	318,741	317,443
Investments in rabbi trust	1,814	1,804
Total fair value assets	321,768	320,596
Liabilities	1,138	1,226
Recurring | Derivative loan commitments
Investment securities available for sale:
Derivative assets	0	126
Recurring | Interest rate swap agreements
Investment securities available for sale:
Derivative assets	1,213	1,223
Liabilities	1,138	1,226
Recurring | Mortgage-backed securities - Agencies
Investment securities available for sale:
Investment securities available for sale, at fair value	139,454	134,890
Recurring | Mortgage-backed securities - Collateralized
Investment securities available for sale:
Investment securities available for sale, at fair value	61,110	62,753
Recurring | Collateralized mortgage obligations
Investment securities available for sale:
Investment securities available for sale, at fair value	18,333	19,810
Recurring | Asset-backed securities
Investment securities available for sale:
Investment securities available for sale, at fair value	14,758	14,758
Recurring | Municipals - Tax-exempt
Investment securities available for sale:
Investment securities available for sale, at fair value	64,361	64,755
Recurring | Municipals - Taxable
Investment securities available for sale:
Investment securities available for sale, at fair value	17,669	17,676
Recurring | Corporate bonds
Investment securities available for sale:
Investment securities available for sale, at fair value	981	984
Recurring | Equity Securities
Investment securities available for sale:
Investment securities available for sale, at fair value	2,075	1,817
Recurring | Level 1
Investment securities available for sale:
Investment securities available for sale, at fair value	1,976	1,718
Investments in rabbi trust	1,814	1,804
Total fair value assets	3,790	3,522
Liabilities	0	0
Recurring | Level 1 | Derivative loan commitments
Investment securities available for sale:
Derivative assets	0	0
Recurring | Level 1 | Interest rate swap agreements
Investment securities available for sale:
Derivative assets	0	0
Liabilities	0	0
Recurring | Level 1 | Mortgage-backed securities - Agencies
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Mortgage-backed securities - Collateralized
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Collateralized mortgage obligations
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Asset-backed securities
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Municipals - Tax-exempt
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Municipals - Taxable
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Corporate bonds
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 1 | Equity Securities
Investment securities available for sale:
Investment securities available for sale, at fair value	1,976	1,718
Recurring | Level 2
Investment securities available for sale:
Investment securities available for sale, at fair value	316,666	315,626
Investments in rabbi trust	0	0
Total fair value assets	317,879	316,849
Liabilities	1,138	1,226
Recurring | Level 2 | Derivative loan commitments
Investment securities available for sale:
Derivative assets	0	0
Recurring | Level 2 | Interest rate swap agreements
Investment securities available for sale:
Derivative assets	1,213	1,223
Liabilities	1,138	1,226
Recurring | Level 2 | Mortgage-backed securities - Agencies
Investment securities available for sale:
Investment securities available for sale, at fair value	139,454	134,890
Recurring | Level 2 | Mortgage-backed securities - Collateralized
Investment securities available for sale:
Investment securities available for sale, at fair value	61,110	62,753
Recurring | Level 2 | Collateralized mortgage obligations
Investment securities available for sale:
Investment securities available for sale, at fair value	18,333	19,810
Recurring | Level 2 | Asset-backed securities
Investment securities available for sale:
Investment securities available for sale, at fair value	14,758	14,758
Recurring | Level 2 | Municipals - Tax-exempt
Investment securities available for sale:
Investment securities available for sale, at fair value	64,361	64,755
Recurring | Level 2 | Municipals - Taxable
Investment securities available for sale:
Investment securities available for sale, at fair value	17,669	17,676
Recurring | Level 2 | Corporate bonds
Investment securities available for sale:
Investment securities available for sale, at fair value	981	984
Recurring | Level 2 | Equity Securities
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3
Investment securities available for sale:
Investment securities available for sale, at fair value	99	99
Investments in rabbi trust	0	0
Total fair value assets	99	225
Liabilities	0	0
Recurring | Level 3 | Derivative loan commitments
Investment securities available for sale:
Derivative assets	0	126
Recurring | Level 3 | Interest rate swap agreements
Investment securities available for sale:
Derivative assets	0	0
Liabilities	0	0
Recurring | Level 3 | Mortgage-backed securities - Agencies
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Mortgage-backed securities - Collateralized
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Collateralized mortgage obligations
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Asset-backed securities
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Municipals - Tax-exempt
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Municipals - Taxable
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Corporate bonds
Investment securities available for sale:
Investment securities available for sale, at fair value	0	0
Recurring | Level 3 | Equity Securities
Investment securities available for sale:
Investment securities available for sale, at fair value	$ 99	$ 99

Fair Value Measurements - Rollf

Fair Value Measurements - Rollforward of Fair Value by Level and Categorized with Level 3 (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Investment Securities Available for Sale
Reconciliation of fair value by level and category
Beginning of period balance	$ 99	$ 99
Unrealized gains included in:
Earnings	0	0
Other comprehensive income	0	0
Purchases	0	0
Sales	0	0
Reclassification from level 3 to level 1	0	0
Issuances	0	0
Settlements	0	0
End of period balance	99	99
Derivative Loan Commitments
Reconciliation of fair value by level and category
Beginning of period balance	126	1,020
Unrealized gains included in:
Earnings	0	0
Other comprehensive income	0	0
Purchases	0	0
Sales	0	0
Reclassification from level 3 to level 1	0	0
Issuances	0	470
Settlements	(126)	(1,364)
End of period balance	$ 0	$ 126

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Average age for loan appraisals, maximum	12 months

Fair Value Measurements - Fai81

Fair Value Measurements - Fair Value of Assets Measured and Recognized on a Nonrecurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 44,453	$ 49,378
Other real estate owned and repossessed assets	5,185	5,345
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned and repossessed assets	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned and repossessed assets	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	44,453	49,378
Other real estate owned and repossessed assets	$ 5,185	$ 5,345

Fair Value Measurements - Range

Fair Value Measurements - Ranges of Significant Unobservable Inputs Used to Value the Companys Material Level 3 Financial Instruments (Details) - Level 3 $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)
Impaired Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 44,453
Significant Unobservable Inputs	9.00%
Other Real Estate Owned
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 5,185
Significant Unobservable Inputs	10.00%

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Fair Values of Those Financial Instruments That are not Recorded at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Level 1
Financial Assets:
Loans, net	$ 0	$ 0
Financial Liabilities:
Deposits	0	0
FHLB borrowings	0	0
Other borrowings	0	0
Level 2
Financial Assets:
Loans, net	0	0
Financial Liabilities:
Deposits	2,617,793	2,573,070
FHLB borrowings	50,000	172,000
Other borrowings	65,303	65,303
Level 3
Financial Assets:
Loans, net	2,348,838	2,448,581
Financial Liabilities:
Deposits	0	0
FHLB borrowings	0	0
Other borrowings	0	0
Carrying Amount
Financial Assets:
Loans, net	2,338,533	2,442,116
Financial Liabilities:
Deposits	2,619,643	2,571,970
FHLB borrowings	50,000	172,000
Other borrowings	38,938	38,813
Fair Value
Financial Assets:
Loans, net	2,348,838	2,448,581
Financial Liabilities:
Deposits	2,617,793	2,573,070
FHLB borrowings	50,000	172,000
Other borrowings	$ 65,303	$ 65,303